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ABSTRACT
Despite concerted efforts to decrease costs and increase public health, the embattled U.S.
health care system continues to struggle to alleviate these widespread issues. Because the
problem of hospital utilizations among patients with heart failure is posited to increase as the
population ages, innovative methodologies need to be explored to mitigate adverse events.
Remote monitoring harnesses the strength of advanced information and communication
technology to affect positive changes in health care quality and cost. By reaching across
geographical boundaries, remote monitoring may support increased access to less costly services
and improve the quality of home health care.
The purpose of the study was to examine the home care quality effects of remote
monitoring technology in patients with heart failure and to provide an economic justification for
its adoption and diffusion. It compared remote monitoring as a potential intervention strategy to
a standard no-intervention group (without remote monitoring). Specifically, it analyzed remote
monitoring as a viable strategy to decrease hospital readmissions and emergency department
visits. It also compared the cost of remote monitoring against the current standard-of-care.
The theoretical framework of Donabedian’s Quality Model was used in the evaluation
of remote monitoring. A retrospective posttest only, case control study design was used to test
the degree which remote monitoring was effective in promoting health care quality (hospital
readmissions and decreased emergency department visits). Retrospective chart reviews were
performed using electronic medical records (EMR). Analysis of Variance, Path Analysis,
Automatic Interaction Detector Analysis (Dtreg), and Cost Outcomes Ratio were used to test the
hypotheses and validate the proposed theoretical model.
iii

No significant difference was noted in remote monitoring and usual care groups. Results
suggested that remote monitoring does not statistically lead to a decrease in heart failure-related
hospital readmissions and all-cause emergency department visits. Results of the cost ratio
analysis suggested that there was no statistically significant difference in the net income between
usual care and remote monitoring; however, data suggest that there were significant increases in
cost and intensity of nursing utilization for the remote monitoring intervention. The Automatic
Interaction Detector Analysis showed that the unfavorable results in hospital readmissions were
due to a decrease in collaborative care and patient education prior to the recommendation for
hospitalization.
The role of nursing care, whether in hospital or community-based care, in heart failure
management is critical to quality outcomes. As the field continues to consider the use of
technology in health care, decision makers should think through the process of patient care such
that preventable hospital readmissions are decreased and patients received quality care.
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CHAPTER ONE: INTRODUCTION
Statement of the Problem
The complexities of the health care environment are exacerbated by escalating health care
costs and decreasing quality. Characterized “as the world’s most expensive yet least effective
[as] compared with other [nations’ health care system], [the] growing health care costs have
made millions of citizens vulnerable” (Kumar, Neha, & Shah, 2011, p. 366). The economic
challenges facing the United States are confounded by the unprecedented growth in health care
spending. This growth is attributed to an increase of chronic diseases and the use of costlier
services. This study highlights the public health and economic crisis confronting the U.S.
population
The escalating cost of health care is unsustainable. In spite of the recent economic
downturn, health care spending continues to increase (Roehrig, 2011). Data obtained from the
Center for Sustainable Health Spending stipulated that, since 1990, the health care share of the
GDP has risen significantly from 12 to 18 percent (Roehrig, 2011). Estimated expenditures in FY
2010 were estimated to be $2.6 trillion, about 18 percent of GDP or $8,402 per person
(Tompkins & Orwat, 2010).
In addition to the rising cost of care, there was a concomitant increase in the population
age. From 2000 to 2010, persons aged 45–64 years grew 31.5 percent to 81.5 million, about 26.4
percent of the total population ("2010 Census Shows Nation's Population is Aging,"). The older
adult population, persons age 65 and older, also experienced fast growth rates. Growth rates were
estimated at 15.1 percent (40.3 million members) or 13.0 percent of the total population ("2010
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Census Shows Nation's Population is Aging,"). By 2025, it is predicted that this age group will
have over 1.2 billion members, or 35 percent of the total population (Bloom & McKinnon, 2010;
Wei-lun, Soe-Tsyr, & Li, 2009).
The demographic change was due to several reasons. In the 1950s and 1960s, there were
dramatic increases in births; seventy-eight million people were eligible for retirement in 2008.
Secondly, due to advances in technology and medicine, life expectancy is expected to increase.
In 2010, life expectancies for males and females were 75 years and 80 years, respectively. This
change represents a 35 percent and 30 percent increase over the last 60 years for males and
females, respectively (Kilgour, 2010). Although these numbers are positive, it presents a
challenge for a health care system with rapidly depleting resources.
This sector of the population uses the greatest amount of health care resources. Martini et
al. (2007) suggest that most of the health care costs are attributed to those that are 75 years and
older. It was estimated that in 2003, the total health care cost for the U.S. was $183 billion
(Hussain & Rivers, 2009). By 2050, costs for older adults are projected to be $379 billion
(Hussain & Rivers, 2009). These data require that society make significant changes in how it
cares for older adults.

Heart Failure
Heart failure (HF) remains one of the most prevalent and costly diagnoses among older
adults (Polisena et al., 2010). The life time risk of developing HF is 20 percent and increases
exponentially with age. The prevalence rate is 20 per 1000 individuals at 65 to 69 years of age
and 80 per 1,000 individuals at 85 years and older (Yancy et al., 2013).
2

The American College of Cardiology and the American Heart Association define HF as a
“complex clinical syndrome that results from any structural or functional impairment of
ventricular filling or ejection of blood” (Yancy et al., 2013, p. 1500). Heart failure refers to the
inability of the heart to adequately meet the body’s needs for metabolic function (Tansey, 2010).
The cardinal symptoms of HF are dyspnea and fatigue. The most prevalent sign is fluid retention,
which may lead to pulmonary or peripheral edema and manifest itself as weight gain
(McMurray, 2010; Yancy et al, 2013). The inability of the heart to properly function may be due
to myocardial infarction, hypertension, malfunctioning of one of the linings of the heart, or one
of the great vessels (Tansey, 2010). Most patients diagnosed with HF have symptoms due to
left ventricular myocardial infarction (Yancy et al., 2013). Patients with HF may be
asymptomatic, accounting for 6 to 21 percent of the population and increases with age (Yancy et
al., 2013). Diagnosis of heart failure is made in light of patient history, findings on examination,
and diagnostic tests (McMurray, 2010). Patients may be classified according to the New York
Heart Association Functional Classification Scale or the American Heart Association (AHA)American College of Cardiology Classification Scale (see table 1) (McMurray, 2010).
Many times heart failure goes undiagnosed, delaying the need for timely medical care.
This results in poor health quality and the inability to proactively treat manageable symptoms.
The goals of HF management programs are to reduce the symptoms, mitigate the need for
hospitalizations, and the prevention of premature death (Lee, & Moser, 2013; McMurray, 2010).
Therefore, the effectiveness of any technology-oriented intervention program would support the
clinical process of providing effective and efficient care.
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Table 1. Summary of Heart Failure Classifications
AHA – American College of
Cardiology

New York Functional Classification Scale

Class I

No functional limitation with ordinary
activity; no signs and symptoms

Stage A

High risk, no signs and symptoms,
no functional or structural deficits

Class II

Mild functional limitation with mild
signs and symptoms with ordinary
activity. Comfortable at rest

Stage B

Structural deficits indicative of
heart disease with no signs and
symptoms

Class III

Significant functional limitations with
signs and symptoms with less than
ordinary activities; comfortable at rest.

Stage C

Symptomatic heart disease with
underlying structural deficits

Class IV

Unable to perform functional activities
without undue discomfort; symptoms
present at rest.

Stage D

Advanced structural deficits with
marked functional limitations
despite medical interventions

Quality Challenges
Heart failure is the most common cause for hospitalizations among persons aged 65 years
and older (Jerant, Azari, & Nesbitt, 2001). The risk of HF increases exponentially with age and
continues to rank as the most frequent cause of hospitalizations (Chen, Normand, Wang, &
Krumholz, 2011; Eriksson, 1995). Although longitudinal studies indicated that aggregate
hospitalization rates have decreased since 1999, HF continues to have a sizeable impact (Chen et
al., 2011). The quality challenges are reflected in high hospital utilizations, mortality rates, and
increased costs of care. Hospital utilizations included hospital readmissions and emergency
department visits.
Hospital Readmissions. Hospital readmissions represent a significant portion of Medicare
costs. Previous research shows that the numbers of hospital readmissions among older adults are
staggering. Repeated hospital admissions due to poor chronic care management account for
much of the costs. Hospital readmissions rose 26 percent from 1996 to 2006 (Ballard et al.,
4

2010). In 2004, unplanned hospital readmissions cost Medicare $17.4 billion, out of $102.6
billion in total hospital payments (Jweinat, 2010). This cost represented 20 percent of all
Medicare beneficiaries that were readmitted to the hospital within 30 days of discharge and 34
percent within 90 days of discharge.
Mortality. Despite pharmacological and technological advances in health care, heart
failure is associated with poor survival (Robertson et al., 2012). Fifty-nine percent of men and 40
percent of women die within five years of the diagnosis of heart failure (Lloyd-Jones et al.,
2010). One in ten patients die within 30 days of diagnosis and, of those who survive, one in four
has a high number of readmissions (Joynt, Orav, & Jha, 2011). The median survival rate after
heart failure readmission was 1.5 years for individuals over the age of 85; three years for those
80 to 85 years of age; and four years or greater for individuals less than 79 years of age
(Robertson et al., 2012). The current status of hospital readmission necessitates watershed
strategies by legislators, health care administrators, and clinicians. The lack of quality care is
highlighted by the high number of mortalities.
Costs. Due to escalating costs, chronic care coordination is a national health priority
(Buntin, Jain, & Blumenthal, 2010). Ding, Yehle, Edwards & Griggs, (2013) estimated that the
cost of HF will increase from $31 billion in 2012 to $70 billion in 2030. Heart failure symptoms
account for 16 percent to 24 percent of readmissions and respiratory ailments for 11 percent to
20 percent (Epstein, Jha, & Orav, 2011). According to Epstein et al., (2011), other diagnoses
contributed no more than six percent combined.

5

Current Standard of Care
Home health care provides post-acute interventions to alleviate the exacerbation of
chronic diseases. Patients are eligible to receive home health care services as long as they remain
homebound and able to demonstrate reasonable progress in clinical and functional status (Riggs
& Madigan, 2012). Objectives in home health care are to restore maintenance and/or improve
functioning. Current standards of care include education in self-care management of symptoms,
pharmacological interventions, and nursing interventions (Eriksson, 1995). The presence of
comorbidities increases the difficulty of self-care management by the patient and the health care
practitioners (Eriksson, 1995). Therefore, remote monitoring is proposed as a strategy to increase
the frequency of clinical interactions.

Remote Monitoring Technology
Remote monitoring is a relatively new use of technology that is currently being
considered to affect positive change in health care quality. It combines advanced information
communication technologies and commercialized biometric sensor devices to address disease
management at a distance, thus facilitating health status monitoring (Chen et al., 2012). Remote
monitoring allows users to be monitored in their preferred living environment with equipment
that transmits health information to/from the patient and to/from the care provider (Sorell &
Draper, 2012). The exchange of valid health information is used for “diagnosis, treatment, and
prevention of disease, evaluation, research, and for continuing education of health care
providers; all in the interest of advancing the health of individuals and their communities”
(Maeder, 2010, p. 239). As an advanced method of information and communication technology,
6

remote monitoring has the potential to change health care delivery, but requires sufficient patient
support and multidisciplinary collaboration (Bos, Carroll, & Marsh, 2008). Health information
must be presented to the patient and clinical team to support decision making (i.e. the right
information should be presented at the “right time,” without requiring undue effort) (Bos et al.,
2008, p. 2).
Remote monitoring may promote quality outcomes by alerting health care professionals
of early warning signs and enabling proactive alleviation of potentially deteriorating conditions.
Advances in telecommunication technology provide information that may assist in early
detection and intervention of acute exacerbations; mitigation of complications from chronic
diseases, and the reduction of preventable hospital readmissions (Anker, Koehler, & Abraham,
2011). It enhances information integration and analysis, thus, it converts information into
knowledge and identifies opportunities for effective intervention (Nobel & Norman, 2003). The
remote monitoring system offers a way in which specific physiological information is
electronically transferred to a health care professional (Anker et al., 2011). Through continuous
feedback mechanisms, remote monitoring can enhance communication efforts by allowing
clinicians to make assessments based upon accurate and timely information. This system
supports the use of evidence-based decision making to promote positive patient outcomes.
Remote monitoring service models use information and communication technologies to
provide remote health care services to decrease health care costs and improve quality (Li, Wang,
Lu, Lin, & Yen, 2012). They are able to overcome geographical barriers between health care
professionals and patients (Anker et al., 2011). Telehome care is defined as the “provision of
care, instruction, and education to patients in their place of residence using telecommunication
7

technologies” (Britton, Engelke, Rains, & Mahmud, 2000, p. 27). Remote monitoring supports
the ability to send data “between participants that are physically separated for the purposes of
clinical care” (Lockamy & Smith, 2009).
The use of remote monitoring in the home care environment is a growing trend in health
care (Gagnon et al., 2009). Home remote monitoring, the use of telecommunication technologies
to monitor patients at home, has received considerable consideration as an acceptable method of
care delivery (Takahashi et al., 2010). Remote monitoring technology is being employed by
many home health agencies to aid in the management of chronic diseases (Cardozo & Steinberg,
2010).

Purpose of the Study
The purpose of the study was two-fold: (1) to examine the home care quality effects of
remote monitoring in patients with HF, and (2) to analyze its cost effectiveness. Specifically, it
examined the potentials, if any, of remote monitoring as a cost-effective alternative to decrease
hospital readmissions and emergency department visits as compared to the comparison group
under current standards of care.

Research Questions
1. To what extent does the cost per outcome justify the use of remote monitoring in
patients with HF?
2. To what degree is remote monitoring in home care used to affect positive change in
the process of care?
8

3. In an effort to decrease the costs of accessible quality care, can remote monitoring be
used as an intervention strategy to affect positive changes in health and cost outcomes
among patients with HF?

Significance of the Study
As the problem of hospital utilizations among older adults with heart failure is posited to
increase as the population ages, innovative technologies need to be explored to mitigate adverse
events. This study added to the body of knowledge on the degree to which remote monitoring
may affect positive change in the health care system. Thus, it provides evidence that may
demonstrate the viability and sustainability of remote monitoring as a home care modality for
patients with HF.
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CHAPTER TWO: LITERATURE REVIEW
Theoretical Framework
The current status of health care has led to the consideration of innovative strategies to
include remote monitoring. However, due to resource constraints, merely trying out a new idea
to see if it works is not an adequate option (Christensen & Raynor, 2003). The medical and
economic environments of many health care organizations deem that too much is at risk.
Therefore, a sound theoretical framework should guide the possible adoption, utilization, and
evaluation of remote monitoring. The Donabedian Quality Model was highlighted in this study to
facilitate the discussion of remote monitoring as an intervention program for home care patients.
Donabedian, a pioneer in health care quality research, developed a framework for quality
improvement (Donabedian, 2005; Glickman, Baggett, Krubert, Peterson, & Schulman, 2007). It
is under his theory of structure -process-outcomes relationships, that Donabedian provides
guidance for the provision and evaluation of quality of patient care. The assumption of
Donabedian’s Model is that there is a positive correlation between structure and process and
process and outcomes (see Figure 1) (Qu, Shewchuck, Chen, & Richards, 2010). This study will
also consider an interaction of structure and process on outcomes.

Structure
Remote
Monitoring

Outcomes

Process
Clinical Care

Health Care Quality

Figure 1. Donabedian Quality Model: Structure, Process & Outcomes.
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Donabedian: Structure
Donabedian’s concept of structure suggests that given the proper framework and tools, adequate
medical care will follow (Donabedian, 2005). In home health care, the influence of social
structure and social environment varies between patients. Remote monitoring provides an
additional structural framework to support medical care. This technological infrastructure
provides a platform in which available medical resources in the form of telephone support and
physiological data can be facilitated and shared. Thus, in the home environment, technology and
the socio-environmental context are inherently inseparable (Orlikowski & Scott, 2008).
“[Technology] is a tool . . . it does not ‘represent’ the work, but it feeds into it, it
structures it in complex ways: it structures communication between health care personnel, shapes
medical decision-making, and frames relationship between personnel and patients” (Berg, 1998,
p.27). From the provider’s perspective, it is a means to facilitate collaborative care. Home care
clinicians provide direct care in a relatively autonomous environment and opportunities to
collaborate with team members are reduced. Therefore, a structure that enhances the process of
collaborative care by promoting more meaningful interdisciplinary interactions is important in a
clinically supported environment.
Current structures for care are embedded in routines and repetitive actions across multiple
actors to deliver care (Goh, Gao, & Agarwal, 2011). Structures and routines are used to ensure
quality through standard operating procedures. Goh et al., (2011) find that enhancing routines via
health information technology can decrease redundancy and increase efficiencies. When remote
monitoring enters into health care, it changes the possibilities for clinicians to provide care due to
the opportunities for interactions (Goh, Gao, & Agarwal, 2011).
11

Technology is potentially effective in overcoming geographical and physical barriers to
medical care. Remote monitoring is currently being examined as a means to reduce health
disparities for persons living in rural areas (Brooks et al., 2013). In the provider-patient
relationship, remote monitoring would act as an intermediary between face-to-face visits. De,
Gargaro, Sciarra, De, Zuccaro, Stirpe, & Calo, (2011) suggested that remote monitoring is more
effective in detecting adverse events than intermittent office visits. The literature also indicates
that remote monitoring technology allows health care information to be transmitted more
frequently than would be permitted by face-to-face visits. This technology allows for an early
detection of physiological deterioration that would otherwise not occur unless a clinician is
physically present (Coughlin et al., 2006).

Donabedian: Process
The process of care refers to the application of information received from remote
monitoring. Cooper and Zmud, as stated in Schwieger et al., (2004), reiterate that effectiveness is
the “ability to take full advantage of the information technology being implemented” (p.239).
This definition goes beyond the mere adoption of technology and seeks efficient application to
demonstrate meaningful use. It also includes the application of technology outcomes; in other
words, the information gained through the technology application process should be applied in
the process of clinical care. In this study, the process of care occurs at two levels once symptoms
are recognized: telephone support and face-to-face visits. Ideally, remote monitoring decreases
the complexity of care by resolving physiological deterioration in HF status via telephone
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support. At this level, remote monitoring has successfully led to desired outcomes. However, if
face-to-face visits are required, then the process of clinical decision-making must occur.
Decision-makers use the information to “perceive, process, and respond” to affect change
in health status (Astley & Van de Ven, 1983, p. 248). Decision-making in health care is the
“process whereby the patient and the clinician have access to accurate information and time to
elicit each other’s view so that they can come to a shared understanding of the best plan of action
. . .” (Bryant, 2012, p. 38). The resulting clinical decision guides the plan of care and the strategy
for implementing such care (Donabedian, 1983). Decision-making occurs in clinical
collaboration and patient-provider interactions.
Clinical Collaboration. Technological tools enhance coordination and continuity of care
by increasing information exchange between providers and organizations to affect patient-level
care (Kazandjian & Lipitz-Snyderman, 2011). As a communicative tool, it brings “knowledge
and expertise to the patient’s location” and narrows the knowledge gap between providers
(Nilsen, 2011, p.1148). The ability for more synchronous exchange of information allows
health care providers greater access clinical data, thus allowing clinicians to collaborate more
effectively with a greater degree of information.
Narrowing this knowledge gap has been suggested to improve quality care (BenhamHutchins & Effken, 2010; Nilsen, 2011). A study by Dendale and colleagues (2011) examined
remote monitoring facilitated-collaboration and its effect on hospital readmission, cost, and
mortality rate. This study found that collaboration supported by remote monitoring technology
allowed practitioners to use the physiological data (i.e. blood pressure, weight, pulse,
temperature) to focus on more at-risk patients (Dendale et al., 2012). The study’s results also
13

suggested that collaboration amongst professionals decreased mortality, hospital readmissions,
and associated health care costs (Dendale et al., 2012). Participants attributed favorable results to
increased information exchange. De et al. (2011) suggested that in patients with heart failure,
remote monitoring provided data that established reliable predictors of adverse events.
Practitioners used this information to enact early interventions and decrease the severity of
symptoms.
Patient-Provider Interactions. Information technology enlists a critical component of
health care—the patient. Patient involvement in their own care is critical to quality outcomes.
Thus, supporting Cleland and Ekman (2010) description of patients as the “largest health care
workforce available” (p. 1382). Improving the long-term outcomes of public health depends on
the ability of this group to be active, confident participants in the pursuit of personal health. As
an intervention strategy, information technology can be used to empower patients, increase selfefficacy, and promote adherence to treatment programs. Technology systems can send
motivational messages to support current adequate self-care management behaviors and increase
their understanding of disease management (Cleland & Ekman, 2010). Increasing selfconfidence in self-care leads to better outcomes (Cleland & Ekman, 2010). Using the Self-care
of Heart Failure Index and the Minnesota Living with Heart Failure Questionnaire, Buck and
colleagues (2012) suggested a positive relationship between confidence in self-care and quality
of life. Their findings suggested that self-efficacy affects the level of performance and
participation for self-care activities
Collaboration with patient and informal caregivers promotes learning and has potential
to improve the quality of care and overall health (Brown, Scott Poole, & Rodgers, 2004).
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Patients may deny symptoms, fail to recognize decline, delay in seeking medical advice, or seek
medical advice prematurely. Patient education of signs and symptoms of a deteriorating
condition is important to improve health outcomes (Peirce, Hardisty, Preece, & Elwyn, 2011).
An Otera-Sabogal et al. (2010) study demonstrated that a proactive, educational approach
statistically improved blood glucose levels, cholesterol, and the overall control of ailments in the
study’s participants. West, Lagua, Trief, Izquierdo, and Weinstock (2010) found that 68 percent
of behavioral goals were met or improved through the use of remote monitoring. This finding
suggested that not all patients are passive participants in remote monitoring, but are rather
engaged in personal health care. However, one criticism of remote monitoring was that
technology increased the layer between physicians and clients (Nguyen, Kahn, & Angus, 2010).
The current health care system operates in a fast-paced environment, with a high degree of
uncertainty and an expanding knowledge base, and remote monitoring may add a layer of
complexity unless partnerships are adequately established.

Donabedian: Outcomes
The field is considering the addition of a technological framework to support decisionmaking (the process of providing clinical care) to promote quality outcomes. The outcome of
care is conceptualized in terms of recovery and restoration of function (Larson & Muller, 2002).
Outcomes are influenced by the degree to which valid information is gained and effectively
implemented to achieve a stated purpose (Schwieger, Melcher, Ranganathan, & Wen, 2004).
Donabedian’s framework posits that a positive relationship between structure and process will
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have a significant influence on patient outcomes (Larson & Muller, 2002). His framework views
structure and process as precursors to favorable quality outcomes.
Quality refers to the avoidance of harm and the optimization of clinical care given
adequate resources to affect the greatest possible health benefit (Donabedian, 1983). Quality may
be conceptualized in this study as decreasing the need for hospital utilization. Appropriate care
refers to the point at which the expected health benefit exceeds the expected negative
consequences ("Evaluating the effects of remote monitoring on quality, access, and cost," 1996).
Appropriate care improves the clinical effects of remote monitoring. The high rate of hospital
utilizations is reflected, in part, on the failure of the health care system to provide quality care.
Those who support remote monitoring envision it as a strategy that can aid in monitoring chronic
diseases before hospital utilization is necessary.
Clinical Outcomes. A literature review by Stuti et al., (2009) found that more studies
showed a positive effect on clinical outcomes, but the proposed cost efficiencies of advanced
remote monitoring were not empirically supported. Jerant et al’s., (2001) finding suggested that
while distance technology can improve hospital readmissions, emergency visits, and cost of care
for patients with HF, home remote monitoring did not offer statistical significant benefits beyond
that which was offered by telephone follow-ups and was more expensive (Jerant et al., 2001).
A Wakefield et al., (2012) study examined clinical outcomes in patients with diabetes and
hypertension, using a comparison group and two levels of intensity of remote monitoring. The
findings suggested that while clinical outcomes improved, as demonstrated by positive results
with A1C levels, there was no statistically significant difference among the groups. Patient selfreport of self-efficacy was also not statistically significant. Another study examined clinical
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outcomes in patients with chronic obstructive pulmonary disease (COPD) and suggested that
remote monitoring was not statistically significant between the intervention group and the
control group (Darkins & Sanders, 2009). Pulmonary function tests were favorable in both
groups; however, this data set suggested remote monitoring was not statistically influential and
noted minimal change in quality of life.
Hospital Utilization. The current interest in remote monitoring technology lies in its
potential to decrease preventable emergency department visits and hospital readmissions. A New
Jersey study found that remote monitoring promoted a decrease in hospital readmissions by
14.93 percent ("Home remote monitoring cuts cardiac readmissions," 2011). Home remote
monitoring was also supported by Antonicelli et al. (2010), whose findings suggested that the use
of remote monitoring decreased hospital readmissions versus the control group (9 ver 26,
respectively, p<0.05) (Antonicelli, Mazzanti, Abbatecola, & Parati, 2010).
Economic Quality. Quality may also be conceptualized as economic quality. Donabedian
addressed the concept of cost in terms clinical efficiency and production efficiency. (HahsVaughn & Onwuegbuzie, 2006). Clinical efficiency refers to the provision of the most
efficacious intervention strategy given a specified amount of money (Donabedian, 1983).
Production efficiency refers to cost associated with the production of care (Donabedian, 1983).
Donabedian et al. (1982) stipulated that improvements in production efficiency allow one to
achieve the same quality of care at decreased costs. This suggests that one can either improve the
quality of care without increasing cost, or reduce cost without decreasing quality. The use of
remote monitoring in health care seeks to optimize concomitantly clinical and production
efficiency (Donabedian, 1983).
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Proponents of remote monitoring tout its medical and economic propensity to reduce
health care costs by decreasing hospital admissions and mitigating adverse events, therefore
reducing emergency department use (Stuti, Susan, & Geetanjali, 2009; Whitten et al., 2002). A
cost minimization study revealed that the principal source of savings from remote monitoring
was derived from decreased hospital readmissions (64 percent) (Johnston, 2000). Other cost
savings were noted in home care costs and technology programs, five percent and 53 percent,
respectively (Johnston, 2000). The consensus of literature on the topic would appear to indicate
that cost reductions were attributed to a reduction in hospital expenditures and indirect patient
costs, such as travel costs (Seto, 2008).
Cost Outcomes Ratio. Cost Outcomes Ratio analysis assists in providing the best
alternatives for care and has significant implications for the justification of allocating limited
resources to support remote monitoring. By comparing alternate intervention programs, one
assesses the relative efficiency and effectiveness of one program over another. Cost Outcomes
Ratio is used to aid health care professionals, administrators, and public health officials in
comparing the costs of various optional interventions with expected health gains (DePanfilis,
Dubowitz, & Kunz, 2008). This comparison is used when one is measuring the remote
monitoring of patients against the use of current standards of care.
A meta-analysis indicated unfavorable outcomes in emergency department visits, hospital
readmissions, hospital length of stay, and cost (Clarke, Shah, & Sharma, 2011). The cost of care
was not justified in the remote monitoring group (Takahashi et al., 2010). Takahashi et al. (2010)
suggested that the remote monitoring group had an estimated cost of $14,678 and the control
group was $10,161. However, the lack of cost accounting measures led to a poor economic
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evaluation of remote monitoring (Takahashi et al., 2010). Appendix D provides a summary of
the paucity of carefully designed economic studies in regards to remote monitoring.
Skilled Nursing Visits. Current trends in home care show increases in service utilization.
Center for Medicare and Medicaid Services (CMS) estimated that in 2008 total home care
spending was $65 billion. The National Association of Home Care’s 2009 report indicated that
approximately 18.4 billion homecare visits were made in 2009, an average of 36 visits per
patient and approximately $146 per patient visit (Thompson, 2012). Dansky et al.’s (2001) study
proposed that home health agencies can economically benefit from remote monitoring by
offsetting the cost of remote monitoring programs by decreasing home visits. This method allows
agencies to provide more patient encounters while decreasing actual home visits/contact time
(Dansky, Palmer, Shea, & Bowles, 2001). This study supported the Kaiser Permanente study that
sets forth that the cost per patient episode was lower for patients in the remote monitoring group
than the comparison group (Dansky et al., 2001).

The Donabedian Quality Model
By using the Donabedian SPC framework to evaluate remote monitoring, this study
considered the critical components of the remote monitoring intervention program.
Consideration was given to influence of structure on process, process on outcomes, and the
interaction of structure and process on outcomes. A conceptual framework for the Donabedian
Quality Model is presented in Figure 2.0.
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Structure and Process
The structure of home health care was modified by the addition of remote monitoring. In
the context of home health care, social environment and living arrangements were considered
alongside the HF diagnosis. Applying Donabedian’s Quality SPO Model, remote monitoring was
conceptualized as the structural component that was influential on the outcomes of care.
Therefore, the intent to treat or the degree to which patients used the remote monitoring system
suggested the degree to which remote monitoring was implemented. Donabedian suggested that
structure influenced the process of providing care (Nuckols, Escarce, & Asch, 2013). The
structural component of the intervention program provided information that enabled the
monitoring clinicians to positively recognize signs and symptoms of heart failure, if they existed.
The recognition of a deteriorating condition initiated the process of care via telephone support.
Through daily clinical monitoring and feedback, remote monitoring was postulated to decrease
the number of home care visits. At the same time, the ability to proactively identify signs and
symptoms of heart failure allowed the monitoring clinician to problem solve, via a root cause
analysis. Ideally, this should decrease the number of skilled nursing visits and alleviate a
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Figure 2 The Conceptual Framework for the Donabedian Quality Model
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potential physiological decline. The complexity of the process increased when the telephone
support was not effective and face-to-face visits were required. The adequate structural support
allowed problem-solving at lower levels of care, decreasing the costs (or complexity) of the
clinical process. Figure 3 is a diagrammatic representation of the ideal structure – process
relationship postulated by remote monitoring.
H1: When structural factors are held constant, better care structure leads to better clinical
process.
H1a: There is a statistically significant difference in skilled nursing utilization between the
standard of care and remote monitoring care groups in patients with HF.
H1b : There is a statistically significant difference in Net HHRG (net income) between the
standard of care and remote monitoring care groups in patients with HF.
H1c: There is a statistically significant difference in agency costs between the standard of
care and remote monitoring care groups in patients with HF.

Structure
Remote Monitoring

Process
Telephone Support
Figure 3. Diagram of the Influence of Structure on Process of Heart Failure
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Process and Outcomes
When the ideal process of care was not resolved via telephone support, the next level of
care must be provided: home care visits by skilled nursing staff. The clinical assessment was
supported by face-to-face visits (comprehensive clinical assessment) and electronically received
health data on physiological status. These activities are critical to the decision-making process,
which propelled the care plan. As a result, clinicians engaged in several decision-making options
designed to mitigate hospital utilization if symptoms were not resolved with telephone support.
The process of providing care was also conceptualized as the decision-making and collaboration
that resulted from the additional information received from remote monitoring. This involved
decision-making by home care nurses who were notified of an unresolved event and provided
face-to-face assessments. From Figure 4, one sees that as the event was unresolved, higher levels
of care were required, utilizing more resources. The following decision-making options were
available: educating patients/caregivers, clinical interventions, notifying the physician, and
hospital recommendations. When decision-making favored less utilization of resources at lower
levels of clinical care, outputs were at acceptable levels. This resulted in favorable outcomes,
including improved health status at the patient level, and increased economic efficiency at the
agency (and potentially the system) level. One can deduce that when collaborative care was
enacted in clinically adverse events, then clinical and economic outcomes were favorable. Based
on this, the following was hypothesized:
H2: When structural factors are held constant, better care process leads to better clinical
outcomes.
H2a: There is a positive relationship between clinician recommendations/decisionmaking and rate of hospital readmissions in patients with HF.
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H2b: There is a positive relationship between clinician recommendations/decision-making
and rate of emergency department visits in patients with HF.

.
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Figure 4. Diagram of Process of Care Relationship to Outcomes for Visiting Nurses
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Complexity of the System

Process of Care

Interaction of Structure and Process on Outcomes
The infrastructure offered by remote monitoring was supported for its ability to support
clinical care by providing information to clinicians. However, the additional information has
little value if not applied in the care process. In this way, structure may have an indirect causal
link on outcomes, requiring an examining of the structure and process as interdependent
components to affect change in outcomes. Therefore, one can postulate that the interaction
between remote monitoring and process may have an influence on health care and cost outcomes
(see Figure 5).
H3: The structure positively affects the process of care that will lead to better care
outcomes.
H3a: Remote monitoring positively affects the process in home health care that will lead
to statistically significant differences in health outcomes for patients with HF.
H3b: Remote monitoring positively affects the process will lead to statistically significant
differences in cost outcomes for patients with HF.

Structure

Outcomes

Process

Figure 5. Diagrammatic Representation of the Interaction of Structure and Process on
Outcomes
Literature Gap
The cumulative body of literature as cited in this chapter is inconclusive. Although
several studies indicated the positive effects of remote monitoring, the high attrition rate of
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participants led to a decrease in the effect size (Tompkins & Orwat, 2010). A systematic review
of the literature by Clark et al. (2007) suggested that the results of telephone support and remote
monitoring in patients with HF were also inconclusive. Although a similar study found that
remote monitoring reduced mortality and increased quality of life, more studies are needed to
affirm such results (Polisena et al., 2010). Appendix C provides a summary of remote
monitoring’s effect on health care quality.
Several studies with positive outcomes suggested that larger sample sizes and an
enhanced methodology were required for valid and reliable findings (Finklestein et al., 2006;
Noel et al., 2004; Tompkins & Orwat, 2010). Polisena et al.’s (2010) review of the literature
revealed that patients known to be in the remote monitoring program received more clinical care
than the control group. The Hawthorne Effect and resultant bias were potentially problematic in
many studies (Polisena et al., 2010; Takahashi et al., 2010). A study that included ten home
health care agencies and examined patients with HF concluded that significant differences
between hospital readmissions and ED visits occurred more frequently in the remote monitoring
group than in the control group at 60 days after start of care, but not at 120 days (Dansky et al.,
2008). However, the small sample size led to a lack of effect size. Desai (2012) posited that
home remote monitoring is not sufficient to affect change in health care quality. He stated that
the critical components of chronic disease management, patient involvement, timely
interdisciplinary communication, and the ability of non-clinical personnel to administer care per
physicians’ instructions were absent (Desai, 2012).
Preliminary studies claim that remote monitoring “works and has a positive clinical effect
and increases the efficiencies in health services and technical usability” (Ekeland, Bowes, &
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Flottorp, 2010, p. 739). Studies that were less confident about the efficaciousness of remote
monitoring in randomized experimental studies remained hopeful about its potential benefits and
recommended further research to solidify results (Ekeland et al., 2010).
Current research offers little economic support for remote monitoring; however, studies
that offer support are often small in scale and are not held to the rigors of empirical research
(McLaren & Ball, 1995). A systematic review by Whitten et al. (2002) found a paucity of studies
that produced “robust and generalizable conclusions” (p. 1437). In light of these findings,
academicians and researchers should strive for more well designed and implemented studies.
More rigorous studies are needed to determine the cost effectiveness of remote monitoring and
its long-term effectiveness and viability (Stuti et al., 2009). To justify its high costs, the use of
technology should be measured against the current standards of practice. Research is needed to
determine the effectiveness and efficiencies of such use.

Chapter Summary
Remote monitoring intervention programs use information and communication
technologies to provide a clinical support structure to improve cost and quality (Li, Wang, Lu,
Lin, & Yen, 2012). They are able to overcome geographical barriers between health care
professionals and patients (Anker et al., 2011). Telemedicine technology provides more than a
method to collect and store health information: it is an intervention strategy to mitigate financial
and medical adverse events associated with HF. Remote monitoring is speculated to increase
patient-provider communication and to enhance the availability of valid information that can be
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used to make efficacious medical decisions. Such decisions can be used to enact early
interventions before more serious, costly medical attention is needed.
By using Donabedian’s SPO quality model, this study proposed to examine remote
monitoring as an intervention program to mitigate the adverse effects of heart failure. Through
the analysis of the program, hospital utilization and economic effects were investigated.
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CHAPTER THREE: METHODOLOGY
This study used a retrospective post test only, case matched design. Not only did this
study add to the body of literature pertaining to the effectiveness of remote monitoring, but it
also included a cost outcomes ratio analysis.

Study Instrument
Data were collected from the OASIS-C (Outcome and Assessment Information Set), via
electronic medical record review. The OASIS-C is the latest version of the OASIS data set to be
used by all Medicare-eligible recipients of home care services on or after January 1, 2010. The
OASIS is the offical data collection tool used by the Centers for Medicare and Medicaid Services
(CMS) for all home health care agencies. The OASIS is required for admission into home health
care and is completed every 60 days (one certification period), and for the following events:
Transfer to Inpatient Facility, Death, and Agency Discharge. Continuing beyond 60 days
requires Recertification of Care OASIS, in which the provider reassesses patients’ clinical and
functional status to ascertain the need for continued services for another 60 day period. Medicare
requires completion of OASIS data set as a means to collect to following patient information:
socio-demographics, environmental factors, support systems, health status, and functional status.
These data provide a clinical assessment of the patients’ current medical status and evidence of
the need for skilled nursing care.The OASIS provides a standarized method to plan care, measure
quality, and determine reimbursement (O'Connor & Davitt, 2012).
The collected data are electronically submitted to CMS. OASIS data was collected by a
qualified home care clinician (registered nurse or licensed physical therapist) through direct
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observation and an interview of the patient and/or caregiver. Due to the nature of this study,
OASIS data collection were completed by registered nurses, employeed by the home health care
agency. Questions used in this study from the OASIS are discussed and displayed in Appendix
G.

Study Variables
Scientific inquiry was used to guide the study and to determine causality, confirm,
describe, predict, or explain the relationship between two variables: remote monitoring and
quality. The exogenous variable was remote monitoring, and was examined in relation to its
influence on the endogenous variables: health care quality and health care cost. Health care
quality refers to hospital utilization [heart failure-related hospital readmission (HF TIF) and total
emergency department visits (TOTALER)] and clinical status (dyspnea). Health care cost refers
to agency cost, the number of skilled nursing visits, and net HHRG (net income).
Unit of Analysis. Unit of the analysis is the patient. Event history was explored to ensure
that unique patients were examined in the study; such that patients with multiple entries into
home care are counted one time. The first home care episode (in the study period) was examined.
Remote monitoring. The intensity of telemonitoring was collected by the primary
investigator. The Phillips Company (manufacturer of the remote monitoring system) collected
and stored data on patient utilization of remote monitoring. Remote monitoring was used daily (7
days a week) in the morning. Data are available on the number of missed/actual remote
monitorings. Patients were asked to use their installed monitoring system one hour after their
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prescribed morning medications. Data were sent to a central station maintained by Phillips,
where a monitoring clinician was able to assess patient status.
Diagnosis. The literature suggested that comorbidities are a significant contributor to
likelihood of hospital utilization and mortality events (Manning, 2011; Muzzarelli et al., 2010).
Therefore, study participants were included in the study based on primary and secondary diagnosis
of HF (ICD-9, categories of 428.00). Diagnosis was quantified in severity as denoted in OASIS
Question M1020.
Functional Acuity. Functional acuity is strongly correlated to morbidity as a significant
predictor of hospitalization (Courtney et al., 2012; Manning, 2011). The maintenance of
functional mobility was postulated to be an important aspect of independent aging, thereby
reducing health care costs and institutionalization (Webber, Porter, & Menec, 2010). Functional
acuity was assessed by the clinician at OASIS Start of Care.
Clinical Acuity. The clinical status of study participants after inpatient hospitalization
may vary. Clinical questions were extracted from the cardiopulmonary portion of the OASIS and
included in the study. Appendix G highlights relevant questions pertaining to clinical status. This
included M1034, which assessed the overall clinical status and hospitalization risk. M1400 was a
measure of patient dyspnea and shortness of breath, commonly associated with heart failure.
M1500 measured symptoms directly related to heart failure and M1510 was included as a
process measure of care.
Cognitive/behavioral status. Changes in cognition are recognized as predictors of hospital
readmission and therefore included in the analysis. A decrease in cognitive status may lead to
hospital utilization. These questions are reflected in M1700 and M1730.
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Race. The literature suggested that race/ethnicity was a significant contributor to hospital
readmissions (Lee et al., 2009; Muzzarelli et al., 2010). Muzzarelli et al. (2010) study indicated
that African Americans experienced significantly more hospitalizations than Hispanics, followed
by Whites. An exploratory study found that while African Americans did not suffer from higher
mortalities than non-African Americans, African Americans had poorer health outcomes (Clarke,
Davis, & Nailon, 2007).
Age. Hussain and Rivers (2009) suggested that health care utilization increases as one
ages; this contributes to the significant increase in cost associated with age. Sylvia et al. (2008)
also suggested that chronic diseases and comorbidities increase concurrently with age.
Gender. The literature was inconclusive about gender as a predictor of health quality.
While some studies demonstrated that hospital admissions were higher for males than females,
others suggested that gender was not a significant independent predictor of hospital utilizations
in patients with HF (Lee, Capra, Jensvold, Gurwitz, & Go, 2004; Robertson et al., 2012). This
factor was recorded in this study for descriptive purposes and case matching.
Socioeconomic status. Zip code was used for case matching for socioeconomic status.
Data was retrieved from the 2010 census bureau to examine median income and educational
level in a given zip code.
Hospital Readmissions. Heart failure-related hospital readmissions are considered in this
study. Hospital readmissions may be direct readmissions or admissions through emergency
departments. Emergency care, with or without hospital readmission, was denoted by OASIS
Question M2300, M2310, and M2430
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Emergency Department Visits. Emergency department visit refers to emergency care
without hospital readmission. Emergency care with or without hospital readmission was denoted
by OASIS Question M2300, M2310, and M2430.
Social Support. Social support was conceptualized as type of help received (Wan &
Weissert, 1981). M2110 Question from the data set reflected the received amount of care needed
by the patient. It assessed the caregiver’s ability and willingness to provide assistance, if needed.
Appendix G displays M2110.
Social Environment. Living arrangement assessed the participant’s living situation and
how frequently caregivers are in the home and are available to provide assistance.
Appendix G displays question M1100.
The home care discharge date was included for all participants for examination of the
period of time (days) services were rendered. This indicator was used to determine the beginning
and ending of a home care episode or 120 days, whichever comes first. The remote monitoring
discharge date was documented for length of time on remote monitoring. Included in this end
point was the number of remote monitoring days that were ordered and how many were actually
completed. This allowed analysis of compliance with remote monitoring program and prevents
self-selection of “compliant” participants that may favorably skew results. This was used in
analysis of participants who completed the remote monitoring program and comparative analysis
of the entire group of those who had “intent” but did not complete it.
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Sampling
Data were gathered from a home health care agency that used remote monitoring. The
sample consisted of all patients who received home health services through the agency and
experienced a recent hospital discharge. The enrollment period included hospital inpatient
discharges from January 1, 2010 to hospital inpatient discharges May 31, 2013. To observe
patient outcomes, the study period was January 1, 2010 to September 30, 2013. Individuals
meeting inclusion criteria were included in the study. Individuals meeting the inclusion criteria
and did not participate in the remote monitoring program were in the comparison/control group.
Due to possible selection bias of successful participants on remote monitoring, all patients
meeting inclusion criteria were selected until suggested sample size was attained, beginning with
January 1, 2010 admissions until May 31, 2013 with study period until September 30, 2013 (end
of enrollment period plus two potential certification periods or 120 days). One researcher
gathered all data. All patients who did not receive remote monitoring and met inclusion criteria
were included for the study.
Inclusion criteria are as follows:
1. Male or female who are Medicare eligible
2.

HF, as primary or secondary diagnosis, and

3.

Under current MD care, and

4. Recent discharge from a long term or acute care hospital.
Exclusion criteria include the presence of any of the following:
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1. Decreased cognition with combative or aggressive character traits such that with a
caregiver, the subject cannot reasonably be expected to complete the intervention, as
determined by a physician and family input, or
2. No telephone access by subject or caregiver, or
3. Functional limitations that inhibit use of remote monitoring system
By definition, power is the ability to find a statistically significant difference when the
null hypothesis is in fact false. In other words, the study seeks to find a difference when a real
difference occurs. The sample size, the alpha level, and the effect size determine the study of
power. The sample size is the number of units available in the study. Effect size refers to the
strength of the relationship or the salience of the treatment compared to the noise in
measurement. The alpha level (set at 0.05) refers to the odds that the observed result is due to
chance. The lower the alpha, the more rigorous the test and the less likely it is that you will make
a type I errors (rejecting the null when it is true). However, by decreasing the chances of type I
errors, one increases the chance of type II errors (failing to reject the null when it is false). Power
analysis was used to estimate sample size. An adequate sample size will increase the likelihood
that the test will be able to detect a difference, if one exists. A sample size that is too small will
lack the precision to produce reliable answers for the investigation. A sample size that is too
large will use unnecessary time and resources for limited gain. The sample size for the
anticipated effect size of 0.10, statistical power level of 0.80, and probability level of 0.05
requires minimum sample size of 200, allowing for missing cases and incomplete data. Using
Cohen’s d and parameter estimation of 10 to 20 participants per parameter, 200 is adequate to
detect the size of the effect, if one exists.
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Clinical Procedures
As a retrospective chart review, data were collected during the treatment programs.
Participants in this study used a remote monitoring system provided and installed by the agency.
The standard system provided all participants with a blood pressure cuff, an electronic scale, and
pulse oximetry all interconnected and placed in the patient’s home. The system was linked to a
central station that was maintained by Phillips. See Figure 6.

Agency

Figure 6 Diagrammatic Summary of Remote Monitoring Procedures.
Each monitoring triggered a process of care: data collection, transmission, evaluation,
notification, and intervention (if needed). Each subject was monitored daily. Three baseline
physiological data were collected at the commencement of the program for participants in the
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intervention group. This baseline was used during the follow-up monitoring to assess significant
physiological variations. Every morning subjects used the installed remote monitoring system
that assessed physiological status. Remote monitoring systems also asked a series of questions in
regards to heart failure, diet, and symptoms, as shown in Table 2. Collected data were
transmitted to the central agency and evaluated. Notification was sent to the respective home
care agency site (see Figure 7) if abnormalities were not resolved via telephone support. The
agency recorded and alerted clinical staff for abnormal readings. Abnormal readings included the
following factors: weight that varies by more than five pounds, blood pressure readings that vary
by more than ten points on systolic/diastolic, heart rate above 120 and below 60, and SO2
saturation below 94 percent. If no reasonable explanations were given for the abnormality, the
visiting nurse contacted the appropriate physician for further orders. Subjects may have been
ordered to the hospital where necessary medical assessments were performed. Upon being
discharged to return home, remote monitoring system resumed. If hospital admission was not
ordered, physician recommendations were followed and home care resumed. Subjects resumed
remote monitoring every morning. During the study, the clinical data for comparison subjects
were emergency department visits and hospitalizations. Guidelines for clinical practice specific
to heart failure were used to guide clinical practice. Guidelines were followed for all patients
diagnosed with heart failure. If remote monitoring was used, then the technology was included in
the plan of care.
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Table 2 Questions from Remote Monitoring Program
1. Are you experiencing more difficulty breathing today compared to a normal day?
2. Have your ankles been swollen more than usual?
3. Have you developed a cough?
4. Are you more tired compared to a normal day?
5. Are you having difficulty following your diet?
6. Are you having any dizziness?
7. Has your doctor added, deleted, or changed any of your medications this week?
8. Have you been having any chest pain?
9. Are you having any headaches?
10. Have you used your nitroglycerin in the last day?
11. Have you had any blurred vision today?

Electronic
Submission

Triage(if
needed)

Yes

Collection
of Date

Telephone
Support

Intervention

Figure 7 Summary of Information Processing for Remote Monitoring.
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Data Collection and Handling
This quantitative research used posttest only control case matched design. Those meeting
the inclusion criteria and who participated in the remote monitoring program were assigned to
the intervention group. Those meeting the inclusion criteria and who did not participate in the
remote monitoring program were in the control group. Retrospective chart reviews were
performed through the review of electronic medical records. IRB was obtained September 2013.

Statistical Analysis Plan
Primary Objective: Quality outcomes. Descriptive statistics (frequency, means, and
standard deviations) were calculated for all demographic and baseline levels of all clinical
outcome variables or endpoints. This calculation provided for the general description of the study
sample. Inferential statistics were used to draw conclusions about the study group and to make
generalizations about a larger class of subjects based on the limited sample of subjects (Wan,
2002). The data analysis included ANOVA, path analysis, structural equation modeling (SEM),
Automatic Interaction Detector Analysis (AID), and an independent t-test.
Secondary Objective: Cost Outcomes Ratio. Descriptive statistics (frequency, means, and
standard deviations) were calculated for all related costs. Cost Outcomes Ratio was used to
analyze the cost per outcome. An independent t test was employed to determine the statistical
significance of the results.
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Propensity Score Matching and Analysis
Random assignment is supported for its statistical advantages to ensure that group
characteristics are relatively equal and differed only in assigned group (Heinrich, Maffioli, &
Vazquez, 2010). However, random assignment is not always feasible in clinical practice. Some
interventions must be developed and implemented prior to study commencement and
cooperation may be costly to obtain (Heinrich et al., 2010). Therefore, non-experimental
evaluation methods are supported to facilitate the understanding of the effectiveness of
interventions despite assignment limitations (Heinrich et al., 2010). Propensity score is a
conditional probability that expresses how likely a participant is to be assigned to a treatment or
control group (Heinrich et al., 2010; Luellen, Shadish, & Clark, 2005; Thoemmes & Kim, 2011).
The goal in propensity scoring is to create a balance in the observed covariates and recreate a
situation that would be expected in a randomized experiment. To avoid selection bias, “matching
methods find a non-treated unit that is similar to a participating unit, allowing for an estimate of
the intervention’s impact as the difference between a participant and the matched comparison
case” (Heinrich et al., 2010, p. 4). Similar to all probabilities, propensity scores range from 0 to 1
(Luellen et al., 2005). In a truly randomized assignment, each person has an equal chance of
being selected in either group (Luellen et al., 2005). In this study, the true propensity score was
unknown. Therefore, propensity score was used to balance non-equivalent groups using
matching and weighting on the propensity score (Luellen et al., 2005).
Statistical software R-program was used for the propensity score matching (PSM) and
analysis. In this study, there are potentially more participants who received remote monitoring
than those who did not. For technical reasons, a larger control group was selected than the group
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receiving the remote monitoring intervention. Treatment participants were matched based on
primary and secondary diagnosis, and clinical acuity components of the OASIS data set (as
related to cardiopulmonary assessments): race, age, socioeconomic status, and gender to a
control participant.
The nearest neighbor matching approach was used to match the comparison with the
intervention group (Austin, 2010). Austin (2010) suggested that nearest neighbor matching
method optimizes the “estimation of treatment effects” (p. 1095). Propensity scores were
computed by modeling a logistic regression with the dependent variable as the probability of
receiving the remote monitoring intervention and the independent variables of age, gender, race,
zip code, and clinical acuity (Sun et al., 2012). A single propensity score was estimated for every
individual in the study and was used to adjust for the difference between the two groups (Reeve,
Smith, Arora, & Hays, 2008). The intervention participants were matched using the generated
propensity score with a participant from the comparison group. Once matched, the pair was
removed from the list of intervention and comparison group and added to the study (Rosenbaum
& Rubin, 1985).
Propensity matching is met with limitations. A strong internal validity was not
guaranteed, as it assumes that all variables related to both outcomes and treatments assignments
are included in the observed covariates (Luellen et al., 2005). The degree of reduction bias
achieved was influenced by the efficiency of the estimators, sample size, and the sources of the
nonequivalent groups (Luellen et al., 2005).
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Data Analysis
Data analysis was performed using Statistical Package for Social Sciences (SPSS)
version 18.0. Descriptive statistics were used to describe the study sample: means, standard
deviation, frequency, and percent, as applicable to categorical and continuous variables.
ANOVA. Inferential statistical analysis was conducted using the analysis of variance
(ANOVA). Separate, one way ANOVA procedures were used to test the significance between
groups (levels of intensity of remote monitoring) for hospital readmissions and emergency
department visits. Tests of normality and homogeneity were conducted to test the assumptions
for the ANOVA procedures.
Split plot ANOVA. A split plot ANOVA design was used to investigate the impact of the
intensity of remote monitoring on clinical status. Tests of equality of variance and equality of
covariance were conducted via Levene’s test and Boxes’ test, respectively.
Path Analysis. It is suggested that the maturity of a scientific discipline is measured by
the complexity and specificity of the questions (Hoyle, 1994). As statistical methods advance, it
is critical that investigators harness and employ appropriate methodologies to address the
complexities of the health care system (Hoyle, 1994). The scarcity of resources available to
many organizations, compared to the large amount of resources required, stipulates that an
intervention be effective across many indicators. Path analysis is a methodology in which one
can visually see the relationships among variables. It assisted in determining to what degree, if
any, can the observed data be explained in terms of the smaller number of factors or predictor
variables (Helitzer et al., 2010). Operationalizations of study variables are noted in Appendix E.
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Structural Equation Modeling (SEM) addresses the “mandate for more flexible and
sophisticated approaches to clinical research questions” (Hoyle, 1994, p. 428). SEM is
appropriate in this analysis due to the consideration of constructs and multiple indicators. The
two step process includes the measurement model and the SEM. The measurement model
provides a representation of how the latent variable is measured in terms of the observed
variables. SEM was used to determine the relationship between the latent exogenous variables,
structure and process, and the latent exogenous variables, cost and quality. Latent exogenous
variable of structure considered the intent to treat of remote monitoring, social support, and
social environment. Latent exogenous variable of process refers to the decision-making options
represented by M1510. Cost will be observed by agency cost, net HHRG, total skilled nursing
visits. Health will be observed by dyspnea status at discharge, hospital readmissions, and
emergency department visits. Operationalization of study variables for this model is presented in
Appendix L.

Donabedian Process Analysis: Dtreg
Patient information at the point of care enhances collaboration such that practitioners,
given a set of predictor variables, are able to affect favorable change in quality outcomes. This
analysis answered the question: by having patient information at the point of care, what is the
relationship between clinical decision-making and hospital utilization? This analysis was based
on an Automatic Interaction Detector Analysis, using Dtreg to strategically detect meaningful
relationships between a set of predictor variables and a dependent variable. Dtreg can be used to
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reveal the relationships among predictor variables that are potentially invaluable to clinicians’
efforts to decrease hospital utilizations.
The first step was to identify predictor variables for hospital utilizations. The literature
posits that patient characteristics of age, sex, race, socio-economic status, co-morbidities (as
reflected in primary and secondary diagnosis), clinical acuity, and functional acuity are
predictors of hospital utilization (Priebe et al., 2011). The literature also suggested that social
support and social environment are perceived as mediating factors, which support patients with
chronic illness (Wan & Weissert, 1981). The second step involved a descriptive analysis
performed by SPSS (version 18). During the third step, a correlation matrix was performed by
SPSS to detect whether there are strong correlations between predictor variables. If a strong
correlation was found at the 0.7 level, then correlated variables were adjusted. Fourthly, AID
analysis was performed to detect the interactions among predictor variables.
The AID analysis has some limitations. The minimum size for each group can affect the
statistical stability. This study used an adequate sample size to minimize this limitation. Because
temporal factors are not specified, causal inferences cannot be made. However, it may help in
revealing the potential direction of causal sequence. Logical interpretations of the model must
be tested with observable evidence and replicated with different samples (Wan, 2002).

Cost Outcomes Ratio
A systematic evaluation of remote monitoring requires consideration of the patient,
provider, and overall impact on the health care system (Ruckdãschel, Reiher, Rohrbacher, &
Nagel, 2006). While considering the medical potentials of remote monitoring to improve public
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health, the attenuating resources of the health care system require decision makers to take a
prudent approach to achieve stated goals. Applying economic principles, one asks: Can remote
monitoring provide at least the same level of care (or better) with fewer resources? (Ruckdãschel
et al., 2006). An economic evaluation was required to determine if the cost saving is justified by
the degree of achievement (Ruckdãschel et al., 2006). Therefore, remote monitoring should be
compared to current standards of care to determine if this provides a cost efficient alternative.
Cost-Outcomes Ratio = Total Cost/Units of Effectiveness
1) Hospital Admission = Total Cost/Hospital Readmission
2) Emergency Department Visits = Total Cost/Emergency Department Visit

The cost analysis examined the cost per outcome as compared to the usual care. In light
of the current literature, remote monitoring was evaluated on its ability to improve health care
quality outcomes, and thus, reduce the cost of health care. Cost studies have significant
implications in helping health care professionals promote evidenced-based care in the most cost
efficient methodology.
The costs of the remote monitoring system included: capital costs of remote monitoring
units, additional employees required to operate the remote monitoring program, and the
difference in nursing utilization. The cost of providing care, including the number of nursing
visits and net HHRG, in one home care episode was obtained from chart reviews. Administrative
and equipment costs were provided by the agency via a profit and loss statement for fiscal year
2012 and January to September 2013. An episode was defined as one admission to discharge
period per patient. Based on the literature review, the assessment of provider level costs was as
follows:
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1) Total TM Cost = (TM Capital Cost –/+ nursing utilization)/observed quality
measure.
2) Total Standard of Practice Cost = (Total Cost of Standard Practice -/+ nursing
utilization)/observed quality measure.
where nursing utilization is the average number of nursing visits in per episode.
Cost effectiveness decisions are guided by several options:
(1) If the two interventions of care being considered are equal in outcomes, then one
considers the least costly option.
(2) If both methods of care are equal in cost, then one considers the most effective
intervention program.
(3) However, if the most costly method produces the better outcomes, then one must
consider incremental cost effectiveness.

Hypothesis Testing
Cost Outcomes Ratio. H1 was tested using independent t test. This was an appropriate
test to use as this study compares the means of two different groups. Process of care measures on
health outcomes was analyzed using AID: Dreg.
The ANOVA, SEM, and path analysis are used to explain the proposed hypotheses (H3).
The path coefficient estimates the causal linkages between the exogenous and endogenous
variables. Path analysis provided a graphical representation of an assumed relationship between
the variables (Wan, 2002). The path coefficient (standardized regression coefficient) was
interpreted as the net change in the endogenous variable that was affected by one standard
deviation change in the exogenous variable (Wan, 2002). Data were analyzed using SPSS Amos
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18. Model criteria included the examination of the solution, measure of overall fit, and detailed
assessment of fit. An examination of the solution determined if the parameters are the right sign
and size, if squared multiple correlations were reasonable, and if measurement errors were
reasonable. Overall fit uses chi-square ratio, and RMSEA <0.05, CFI > 0.9, GFI > 0.9, and AGFI
> 0.9. The goodness of fit index measured the degree to which the amount of variance and
covariance can be accounted for by the model. The AGFI is the GFI, but it also accounted for
degrees of freedom. The root means square area of approximation measured the discrepancy in
fit per degrees of freedom. P-value > 0.05 allowed the inquirer to accept the null that the model
fits the data. Detailed assessment of the fit using modification indices was used to determine the
lack of model fit. Poor model fit was improved by eliminating parameters that are not
statistically significant. (Wan, 2002)
As an extension of regression, SEM provided a graphical presentation of the relationship
between the study’s variables (Wan, 2002). The structural model corresponded to the models
interested in the relationship among the exogenous and endogenous variables (Hoyle & Smith,
1994). By using a confirmatory approach, the proposed structural model was based on a
theoretically informed framework (Hox & Bechger).

Chapter Summary
This study used scientific inquiry via a retrospective post test only, case matched design.
Not only will this study add to the body of literature for the efficaciousness of remote monitoring
to promote quality, but it also added a Cost Outcomes Ratio that provided a comparative analysis
against traditional models of health care delivery. The unit of analysis was the patient, with a
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diagnosis of HF, who had recently discharged from long term or acute care hospital, and
admitted to a home health care agency. Study variables were collected from the OASIS C data
set.
The agency of interest was a national home care agency, 70 of its offices provided the
remote monitoring services. Due to possible selection bias of successful participants on remote
monitoring, all patients meeting inclusion criteria were selected until the suggested sample size
was attained, beginning with January 1, 2010 admissions, until May 31, 2013 with study period,
and until September 30, 2013 (end of enrollment plus two potential certification periods or 120
days).
Clinical Outcomes. This study used propensity score matching, via nearest neighbor
matching to create relatively equal groups based on specified variables. Analysis of variance was
used to test the hypothesis and path analysis was used for pictorial representation of the
relationship between the variables and the outcomes of interest, hospital readmissions, and
emergency room visits. Split plot ANOVA was used to examine the effect on remote monitorig
on clinical outcomes. Remote monitoring provided a digital infrastructure to the home health
care program, therefore Dtreg was used to investigate the process outcomes of participants with
heart failure symptoms, i.e. how the clinical decision-making process affects hospital utilization.
Cost Ratio Outcomes. Cost was assessed via an independent t test and Cost Outcomes
Ratio to determine, based on the specified decision-making rule, the program that warrants the
most consideration. Cost was analyzed from the agency perspective.
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CHAPTER FOUR: RESULTS
Propensity Score Matching and Analysis
Propensity score matching was performed to promote a relative balance in the observed
covariates. The analysis was performed using R-Project.Org with the subroutine of Matchit.
Matching was performed using the following covariates: age, gender, median income, median
educational level, and clinical acuity. Three hundred twelve potential participants entered the
propensity score analysis (207 control and 105 treated), 105 were matched and 102 were
unmatched. Logistic regression generated the propensity score for each patient. R
Distribution of Propensity Scores
Unmatched Treatment Units

Matched Treatment Units

Matched Control Units

Unmatched Control Units

0.2

0.3

0.4

0.5

0.6

0.7

Propensity Score

Figure 8 Results of Match Covariates after Propensity Score Analysis

Descriptive Statistics
Descriptive statistics are provided using SPSS version 18.0. The total sample size was
210 (105 in usual care and 105 in the intervention group). The sample consisted of participants
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from 23 offices across the continental United States from one parent organization. The average
age was 77.7 years and 76.7 years, usual care and intervention group respectively. Table 3.0
displays the results for both groups. The descriptive analysis shows that Total ER visits reflected
four percent of the total sample, well below the national average of 12 percent for home health
care agencies. Data suggest no ER visits were due to heart failure symptoms. Total HA was 34.8
percent of total sample, which was significantly above the 17 percent national average. Hospital
readmission rate due to heart failure reflects 24.6 percent of the total readmissions. See Appendix
I Table 1 and Figure 1 and Table 2 for a summary of reasons for Total HA and ER.

Table 3 Descriptive Statistics for Usual Care and Remote Monitoring Groups

Description
Male
Female
White
Black
Hispanic
Asian
Total ER
Total RA

Frequency
49
56
49
13
4
0
3
35

Usual Care
(n = 105)
Percentage
46.7
53.3
82.9
12.4
3.8
2
2.85
16.7

Frequency
46
59
46
12
6
1
2
38

Intervention
(n = 105)
Percentage
43.8
56.2
81.9
11.4
5.7
1
1.9
18.1

Analysis of Variance
One way ANOVA was used to examine the differences, if any, in hospital readmissions
due to heart failure. The independent variable: intent to treat (ITT) was presented in five levels of
treatment compliance: 0 = 0 percent completion of any remote monitoring, 1 = .001 to .25
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completion of remote monitoring, 2 = .26 to .50 of remote monitoring completion, 3 = .51 to .75
completion of remote monitoring; and 4 = 0.76 to 1.00 completion of remote monitoring as
ordered by prescribed physician. However due to small sample size in group 1, group 1 (n = 2,
mean = 0.00), group 2 (n = 8), and 0 (n = 118) were combined to group 0 (n = 128); based on
similarity of HF TIF mean (Heart failure-related hospital readmissions). Results of HF TIF are
reflected in Table 4.
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Table 4 Summary of Descriptive Statistics for Heart Failure-related Hospital Readmissions

0
3
4
Total

N

Mean

Std. Deviation

Std. Error

128
15
67
210

0.14
0.47
0.09
0.15

0.349
0.516
0.288
0.356

0.031
0.133
0.035
0.025

95% Confidence
Interval for Mean
Lower
Upper
Bound
Bound
0.08
0.2
0.18
0.75
0.02
0.16
0.1
0.2
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Minimum

Maximum

0
0
0
0

1
1
1
1

ANOVA testing assumed that the data in each group are random samples from the same
population, samples are independent, and observations within the group are independent. The
Levene’s Test displayed a probability coefficient of 0.000. Since this value is less than 0.05, the
null hypothesis of equal variance is rejected and a difference between the variances in the sample
was considered. The assumption of homogeneity of variance was not supported. Normal
distribution was not supported. However, the F test is robust.
Table 5 Summary of ANOVA Results of Heart Failure-related Hospital
Readmissions
Sum of
Squares

df

Mean
Square

Between Groups

1.759

2

0.88

Within Groups

24.665

207

0.119

Total

26.424

209

F
7.381

Sig.
0.001

Heart Failure Hospital Readmissions. There was a statistically significant difference at
the p<0.05 level; F (4, 207) = 7.381, p = 0.001. Therefore, we reject the null and consider that
the use of remote monitoring in home health care will lead to statistically significant difference
in hospital readmissions in patients with HF. A Post Hoc comparison using Tamhanes test
indicated that the mean score for group 3 was statistically significantly different from group 0 (M
= 0.14, SD = 0.349) and group 4 (M = 0.09, SD = .288).
Emergency Department Visits. There was no statistically significant difference at the p <
0.05 level for hospital utilization as defined as emergency department visits. F (4, 205) = .211, p
= 0.932. Therefore, we fail to reject the null and consider that there is no statistically significant
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decrease in emergency department visits. Analysis suggests that no emergency department visits
without hospital admissions were due to heart failure symptoms.

Path Analysis
Heart Failure Hospital Readmissions. The path analysis was performed to show the
strength of the relationship of the hypothesized association between variables. The path analysis
was completed using Amos 18.0 software to estimate the path coefficients for the model. An
initial model (see Figure 9) was developed using as the following predictors: intent to treat (ITT),
age, race, gender, HF severity, COPD severity, dyspnea (M1400), M1034, M1100, M2110,
Clinical acuity (CA) and functional acuity (FA) on the target variable HF TIF. Model fit
summary indicated p value < 0.05 (N = 210, p value = 0.000; Chi squared = 132.987, 55 DF;
x2/DF= 2.418; RMSEA = 0.082 CFI = 0.114; GFI = 0.883 and AGFI = 0.849). A revised model
was generated using modification indices and correlation notes from the model. Model notes
suggested a relationship between clinical acuity and M1034, M2110 and intent to treat, M1034
and intent to treat, and functional and clinical acuity. A revised model suggests, as indicated in
Figure 10, that predictors accounted for 9% of the variance in HF TIF. Clinical and Functional
Acuity were the most significant predictors of hospital readmissions. The model fit for this
model was found to be acceptable at p value > 0.05 (N = 210, p value = .201; Chi squared =
14.608, 17 DF; x2/DF= 1.328; RMSEA = 0.040; CFI = 0.933; GFI = 0.980 and AGFI = 0.950).
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Figure 9 Proposed Path Analysis on the Predictors of Hospital Readmission
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Table 6 Goodness of Fit Statistics for Heart Failure-related Hospital
Readmissions
Fit Indices
Chi Squared
Pvalue
DF
x2/df
RMSEA
CFI
GFI
AGFI

Criterion
Low
> 0.05
>0
>0
< 0.04
> 0.90
> 0.90
> 0.90

Original Model
132.987
0.00
55
2.418
0.082
0.114
0.883
0.849

Revised Model
14.608
0.201
17
1.328
0.04
0.933
0.98
0.95

Table 7 Standardized Estimates of the Revised Path for Heart Failure-related
Hospital Readmissions
Standardized Unstandardized
Estimates
Estimates
HFTIF
HFTIF
HFTIF
HFTIF
HFTIF
HFTIF
HFTIF

<--<--<--<--<--<--<---

COPD
M1034
ITT
M1100
M2110
CA
FA

-0.137
0.08
0.006
-0.135
-0.044
0.136
0.102

-0.042
0.046
0.006
-0.018
-0.002
0.005
0.011
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S.E.

C.R.

0.02
0.039
0.061
0.009
0.003
1.895
1.452

-2.067
1.173
0.094
-2.05
-0.663
0.058
0.147

P
0.039
0.241
0.925
0.04
0.507

Figure 10 Revised Path Analysis of the Predictors of Hospital Readmission
Emergency Department Visits. The original hypothesized model depicted the
arrangements of exogenous variables and their correlations with the endogenous variables, as
shown in Figure 11. Chi-squared was 200.151, DF 105, p value = 0.000, x2/DF = 1.906; CFI =
0.079, GFI = 0.883, AGFI = 0.849, and RMSEA = 0.066. Based on the correlation matrix and
modification indices on the original model, indicators that negatively affected the model were
deleted. The model was revised with the remaining variables. The revised model suggested that
the predictors accounted for 9% of the variance on TOTALER. Clinical Acuity and M1034
(Overall patient status) were found to be the greatest contributors to emergency department visits
without hospital readmissions. The model fit for this model was found to be acceptable at p value
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> 0.05 (N = 210, p value = 0.662; Chi squared = 4.985, 7 DF; x2/DF = .712; RMSEA = 0.000;
GFI = 0.992, AGFI = 0.976, CFI = 1.000). See Figure 12.
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Figure 11 Proposed Path Analysis on the Predictors of Emergency Department
Visits
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Table 8 Goodness of Fit Statistics for All Cause Emergency Department Visits

Fit Indices
Chi Squared
Pvalue
DF
x2/df
RMSEA
CFI
GFI
AGFI

Criterion
Low
> 0.05
>0
>0
< 0.04
> 0.90
> 0.90
> 0.90

Original Model

Revised Model

200.151
0.00
105.00
1.906
0.066
0.079
0.883
0.849

4.985
0.662
7.00
0.712
0.00
1.00
0.992
0.976

Figure 12 Revised Path Analysis of the Predictors of Emergency Department Visits

61

Table 9 Standardized Estimates from the Revised Model of All Cause Emergency
Department Visits
Standardized
Estimates
TotalER
TotalER
TotalER
TotalER
TotalER

<--<--<--<--<---

Race
HF
M1034
ITT
CA

Unstandardized
Estimates

0.1
0.083
0.128
-0.064
0.138

0.029
0.02
0.032
-0.026
0.004

S.E.
0.019
0.017
0.018
0.027
0.002

C.R.

P

1.496
1.224
1.828
-0.937
1.999

0.135
0.221
0.068
0.349
0.046

The results also indicated that participants receiving remote monitoring and who
completed 51 to 75 percent of the monitoring had higher hospital readmission rates. Therefore,
further analysis was warranted. Descriptive statistics are provided in Table 10.
An Analysis of Variance considered potential differences in heart failure symptoms
between groups. The Levene’s Test displayed a probability coefficient of 0.013. Since this value
was less than 0.05, we reject the null hypothesis of equal variance and consider that there is a
difference between the variances in the population. The assumption of homogeneity of variance
was not supported. While mean heart failure symptoms increased for group 3, p value > 0.05 (p
= 0.083), statistical significant is not supported. However, clinical significance may be noted due
to the relative increase in heart failure symptoms for group 3 as compared to groups 0 and 4. See
Table 11 and Figure 13.
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Table 10 Summary of Results of Descriptives of HF Symptoms

0
3
4
Total

N

Mean

Std.
Deviation

Std. Error

128
15
67
210

0.24
0.47
0.19
0.24

0.43
0.516
0.398
0.43

0.038
0.133
0.049
0.03

Table 11

95% Confidence
Interval for Mean
Lower
Upper
Bound
Bound
0.17
0.18
0.1
0.18

Min

Max

0
0
0
0

1
1
1
1

0.32
0.75
0.29
0.3

Summary of ANOVA Results

Between Groups
Within Groups
Total

Sum of
Squares
0.911
37.703
38.614

df
2
207
209

Mean
Square
0.456
0.182

F

Sig.

2.501

0.084

Figure 13 Graph of Heart Failure Symptoms and Heart Failure Hospital
Readmissions
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A split plot ANOVA design was used to investigate the impact of remote monitoring
(intent to treat as categorized above) on clinical status. Clinical status will be conceptualized as
dyspnea (M1400), as a principle manifestation of heart failure as captured by the OASIS. The
cases selected for analysis were those who had both the pre and post tests completed.
Dyspnea (M1400). A summary of descriptive statistics for dyspnea is presented in Table
10. Levene’s test of Equlaity of Error Variance and Box’s Test of Equality of Covariance
Matrices suggested that the assumptions were violated (Table 12). Mauchly’s Test of Sphericity
was violated as indicated by the p = 0.00 however, this mulitvariate analysis does not require
sphericity. Wilks’ Lambda for interaction effect was not significant at p = 0.343 however, there
was a statistically significant effect for time p = 0.000 with a large effect size (Partial Eta
Squared = 0.228). The between subject effects are significant at the p = 0.02 level.

Figure 14 Plot of Pretest and Posttest of Dyspnea across Remote Monitoring Intent
to Treat
64

Table 12 Summary of Results of Key Statistical Assumptions
Levene's Test of
Equality of Error
Variance
Dyspnea (M1400)
Dyspnea (M1400
DC)

F
2.219

Sig
0.112

0.677

0.51

Box's Test of
Equality of
Covariance
Matrices
F
Sig
1.171

0.319

Table 13 Summary of Descriptive Statistics for Intent to Treat and Dyspnea
Dyspnea (M1400)

Dyspnea (M1400 DC)

Intent to Treat
0
3
4
0
3
4

Mean
2.18
2.5
2.46
0.95
1.88
1.2

Std. Deviation
0.94
0.535
1.026
0.944
0.991
1.034
Total

N
96
8
56
96
8
56
160

Automatic Interaction Detector Analysis: Process
This analysis used an Automatic Interaction Detector Analysis (AID Dtreg) to
strategically detect meaningful relationships amongst a set of predictors. This statistical tool was
used to reveal a potentially overlooked relationship between predictor variables that are
potentially invaluable to an organization’s attempt to decrease hospital utilization. Following the
ANOVA and Path Analysis, Dtreg was used to explain the process portion of the integrated
Donabedian Quality Model. The AID Dtreg was used to understand decision-making at the point
of care when clinically adverse characteristics were recognized. Since the remote monitoring
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system supported clinical decisions related to the symptoms of heart failure, and these data sets
suggest no ER visits were due to heart failure symptoms, only hospital readmissions due to heart
failure were considered in the analysis. The decision tree analysis used heart failure-related
hospital readmissions (HF TIF) as the target variable.
The variables used in this analysis were identified in the OASIS C. CMS incorporates
process and outcome measures to assess the health care services provided, measures agency
performance over various elements of care, and identifies areas in need of improvement
(Niewenhous, 2010). OASIS C included outcomes measures of hospital utilization, denoted by
emergency department use without hospitalization and emergency department use with
hospitalization (hospital readmission). These questions are intended to reflect the actions taken
by the clinical staff when heart failure symptoms were acknowledged. The first step was to
identify decision-making options once it has been determined (in Question M1500) that heart
failure symptoms were present. Options for questions M1510 include: 0 - No action taken (1510
-0); 1 - Patient’s physician (or other primary care practitioner) contacted the same day (1510-1);
2 - Patient advised to get emergency treatment (e.g., calls 911 or go to emergency room) (15102); 3 - Implemented physician-ordered patient-specific established parameters for treatment
(1510-3); 4 - Patient education or other clinical interventions (1510-4); 5 - Obtained change in
care plan orders (1510-5).
A descriptive analysis was performed by SPSS (version 18). Of the 210 included in the
entire analysis, 55 were identified as having symptoms of heart failure by OASIS Question
M1500 (27 from usual care and 28 from the intervention group). Of those who had symptoms of
heart failure, 20 patients (37%) had no hospital readmission and 33 (61.1%) experienced at least
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one hospital readmission, leaving one participant with a hospital readmission that was not
assessed by the clinician prior to readmission.
Thirdly, while a correlational analysis was performed by SPSS to determine if there was
a strong correlation among decision-making variables, none were noted. Lastly, an Automatic
Interaction Detector Analysis, using DTreg, was used to identify how decision-making predicted
hospital readmissions. The AID suggested that the most frequent clinician decision made upon
finding of a heart failure symptom was to send to the hospital. Data suggest that 51 participants
had symptoms of heart failure. Participants that were advised to go to the ER had a 1.00
probability of doing so, and those who were instructed otherwise had a 0.37 probability of
hospital readmission. Among participants who experienced a hospital readmission, there was
0.50 probability that patient education or other clinical intervention was implemented prior to the
admission. If no clinical education or intervention was received then there was a 0.67 probability
of notifying the patients’ physicians the same day. Data suggests that other clinicians’ options to
mitigate hospital readmissions were not used significantly in this sample. Total variance
explained by the model was 47.12 percent. See Figure 15 and Table 14.
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Figure 15 Dtreg Analysis of the Effects of Clinical Decision-making on Hospital
Utilization
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Table 14 Results of the Automatic Interaction Detector Analysis Dtreg

Variable of importance
M1510-2

Patient advised to get emergency treatment
(e.g., call 911 or go to emergency room)

M1510-1

Patient's physician (or other primary care
practitioner contacted the same day)

M1510-4

Patient education or other clinical interventions

100

12.271
10.737

Structural Equation Modelling
Structural Equation Modeling was used to provide a statistical analysis and visual
representation of the interaction between structure and process and its influence on outcomes (as
defined by cost and health outcomes). Model criteria included the examination of the solution,
measure of overall fit, and detailed assessment of fit. Examination of the solution determines if
the parameters are the right sign and size, squared multiple correlations are reasonable, and
measurement errors are reasonable. Overall fit uses chi-square ratio, and RMSEA <0.04, CFI >
0.9, GFI > 0.9, and AGFI > 0.9. The goodness of fit index measures the degree to which the
amount of variance and covariance can be accounted for by the model. The AGFI is the GFI, but
also accounting for degree of freedom. The root means square area (RMSEA) of approximation
measures the discrepancy in fit per degrees of freedom. P-value > 0.5 allows the inquirer to
accept the null that the model fits the data. Detailed assessment of the fit using modification
indices was used to determine the lack of model fit. First, a measurement model was proposed to
examine the interaction, if any, between process of care (decision-making) and structure (remote
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monitoring). Process of care refers to decision-making as indicated by M1510 from the OASIS.
Structure was conceptualized as social environment (M1100), social support (M2100), and
remote monitoring. The measurement model was assigned a regression weight of one to lambda
for each latent exogenous variable. Modification indices were used to identify the sources for
model improvement. Figure 16 shows the proposed model and Figure 17 displays the revised
model. While Table 16 indicates good model fit, the model suggests little interaction between
structure (remote monitoring) and process of care (estimate = -0.001, S.E = 0.002, C. R. = 0.415, P = 0.678). A comparative summary of the standardized estimates are displayed in Table
15.

Figure 16 Proposed Measurement Model of Structure and Process
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Figure 17 Revised Measurement Model of Structure and Process

Table 15 Summary of Standardized Estimates of Structure and Process Model

@15105
@15104
@15103
@15102
@15101
@15100
M2110
ITT
M1100

<--<--<--<--<--<--<--<--<---

Process
Process
Process
Process
Process
Process
Structure
Structure
Structure

Original
Estimates
0.699
0.686
0.57
0.219
0.495
-0.087
0.56
0.275
-0.332
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Revised
Estimates
0.724
0.692
0.555
0.155
0.469
-0.103
0.513
0.272
-0.376

Table 16 Goodness of Fit Statistics for Structure Process Model
Fit Indices
Chi Squared
Pvalue
DF
x2/df
RMSEA
CFI
GFI
AGFI

Criterion
Low
> 0.05
>0
>0
< 0.04
> 0.90
> 0.90
> 0.90

Original
Model
48.903
0.004
26
1.881
0.065
0.817
0.952
0.917

Revised
Model
23.87
0.411
23
1.038
0.013
0.995
0.976
0.953

Secondly, a measurement model of cost and health was proposed in Figure 18. The
measurement model was assigned a regression weight of one to lambda for each latent
exogenous variable. The model was revised (Figure 19) based on modification indices. Cost was
conceptualized as agency cost (ACost), net HHRG, and skilled nursing visits (TotalVisits).
Health outcome was defined as hospital readmission (TotalRA), emergency department visit
(TotalER), and dyspnea (M1400DC). Table 17 shows standardized estimates of the original and
revised models.

Figure 18 Proposed Measurement Model of Health and Cost Outcomes
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Figure 19 Revised Measurement Model of Health and Cost Outcomes

Table 17 Summary of Standardized Estimates of Health and Outcomes Model

TotalVisits

<---

F1

NetHHRG

<---

F1

ACosts
TotalRA
TotalER

<--<--<---

F1
Health
Health

M1400DC

<---

Health

73

Original
Estimate
1.045

Revised
Estimates
1.044

0.727
0.9
0.568
0.135

0.731
0.9
0.564
0.144

0.77

0.783

Table 18. Summary of Goodness of Fit Statistics of Outcomes Model
Fit Indices

Criterion

Original
Model

Revised
Model

Chi Squared
Pvalue
DF
x2/df
RMSEA
CFI
GFI
AGFI

Low
> 0.05
>0
>0
< 0.04
> 0.90
> 0.90
> 0.90

13.282
0.15
9
1.476
0.048
0.994
0.98
0.953

3.84
0.798
7
0.549
0
1
0.994
0.982

Based on the revised measurement models of exogenous and endogenous variables, a
covariance structural model was used to explain the relationship between the latent endogenous
and latent exogenous factors, as seen in Figure 20. Modification indices made no significant
suggestions for improvement to the model, therefore a revised model was not indicated.
Summary of the estimates are presented in Table 19.

Figure 20 Proposed Measurement Model of the Structure and Process Influence on
Outcomes
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Table 19 Summary of Standardized Estimates of Structure and Process Influence on
Outcomes Model

F1
Health
F1
Health
TotalVisits
NetHHRG

<--<--<--<--<--<---

Process
Process
Structure
Structure
F1
F1

Standardized
Estimate
0.106
0.102
0.12
-0.05
1.038
0.739

ACosts
TotalRA
TotalER
M1400DC
@15105
@15104
@15103
@15102
@15101
@15100
M1100
M2110
ITT

<--<--<--<--<--<--<--<--<--<--<--<--<---

F1
Health
Health
Health
Process
Process
Process
Process
Process
Process
Structure
Structure
Structure

0.905
0.551
0.139
0.804
0.714
0.694
0.561
0.172
0.469
-0.093
-0.365
0.498
0.339

Cost Outcomes Ratio
The calculation of average cost per participant was performed. Cost data, such as the
number of skilled nursing visits, cost per nursing visit, net HHRG, and the intervention program
costs, were obtained through the billing department of the agency and the clinical record. An
intervention program cost includes equipment, monitoring, maintenance, marketing, and
additional personnel cost, approximately $300 per patient on remote monitoring. The average
annual program costs are seen in Table 20. Average annual program costs were calculated from
2012 actual program cost per month and 2013 program cost from January to October. November
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and December 2013 was then estimated from the given data. Annual program costs were
averaged for the 2012 and 2013 program.
Table 20 Summary of Average Annual Remote Monitoring Program Cost

Equipment Cost

Annual
Hardware, monitoring, warranty $179,151
costs
$284,230

Additional Personnel
+ benefits
Gross program annual costs

$472,381

An independent t-test was used to compare group means of number of number skilled
nursing visits and agency costs in two separate analysis. The advantage of using a robust test was
that a fairly accurate probability could be obtained even if the populations do not have the
assumed characteristics of normal distribution and random sampling (Spatz, 2005). An
independent t test was performed to examine costs between usual care and remote monitoring
groups.
Statistically significant differences were indicated for skilled nursing visits and agency
costs, p value of 0.002 and 0.000 respectively. Statistical significance was not indicated for Net
HHRG, p = 0.920. Results of the independent t test are presented in Table 13.
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Table 21 Summary of Results of Independent T Test for Remote
Monitoring

Usual Care

Skilled Nursing Visit
Net HHRG
Agency Cost

(n=105)
Mean Std Deviation
13.05
8.006
$ 2,643.76
1600.11
$ 521.90
320.26

Intervention
(n=105)
Mean
17.06
$ 2,624.13
$
982.29
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Std Deviation
10.009
1189.06
403.97

Levene's Test

0.072
0.011
0.072

P value

0.0020
0.9200
0.0000

The benefits of the program refer to the net program costs and number of skilled visits
reflected in each group. The average cost per skilled nursing visit is $40. The average number of
skilled nursing visits in the comparison group was 13.05 visits, and the intervention group was
17.06 visits. Net HHRG was actual payments received per episode of care per patient. Average
Net HHRG was $2643.76 and $2624.12, the comparison and intervention group respectively.
Average cost difference (exp. – comparison)/Difference in changes of an outcome
measure between the exp. & comparison groups;
ER: $982.29 - $521.90/2 (where 2 ER visits is the difference in outcomes between the
exp. & comparison groups) = $230.195
Total HF TIF: $982.29 - $521.90/1 (where 1 HA visits is the difference in outcomes
between the exp. & comparison groups) = $460.38
Monthly cost due to additional benefit of decreased EDV and HF TIF is $230.195. Thus, the
remote monitoring was not a cost effective alternative to usual care. Based on the following
decision-making rule:
(1) If the two interventions of care being considered are equal in outcomes, then one
considers the least costly option.
(2) If both methods of care are equal in cost, then one considers the most effective
intervention program.
(3) However, if the most costly method produces the better outcomes, then one must
consider incremental cost effectiveness.
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One should consider Option 1. The agency does not overcome the cost of the remote
monitoring program and statistically insignificant differences in hospital utilization outcomes
suggest that other alternatives should be considered.

Chapter Summary
Prior to hypothesis testing, propensity score analysis using R software was performed to
balance the observed covariates between the two groups. Hypothesis testing was performed to
systematically test the statistical significance of the findings. First, a descriptive analysis was
performed to understand the sample characteristics and the performance of the agency in
consideration to national norms. Data suggest that while all-cause EDV visits were below
national average, all cause hospital readmissions were well above national average. Hospital
readmissions related to heart failure where slightly above the national average of 16 to 23
percent. Path Analysis was incorporated into this study to further elucidate the influence of the
intent to treat in remote monitoring on hospital utilization.
There was no statistically significant difference at the p < 0.05 level for hospital
utilization as defined by emergency room visits. F (4, 205) = 0.211, p = 0.932. Therefore, we fail
to reject the null and consider that there is no statistically significant decrease in emergency
room visits. Statistical significance suggested a difference in pre and posttest measures for
dyspnea. The intensity of remote monitoring indicated between group differences for dyspnea.
A structural equation model suggests that remote monitoring had little interaction with
process of care. Therefore the interaction of structure and process was not significant influential
in the outcomes of care.
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Results of the t test suggested that there was no statistically significant difference at the
p< 0.05 level. Therefore, we fail to reject the null hypothesis and consider that there is no
difference in the Net HHRG between usual care and remote monitoring. Because statistical
significance was noted for agency cost and skilled nursing visits, we therefore reject the null and
consider that there is a difference between usual care and remote monitoring groups.
Due to the two interventions of care being considered equal in outcomes, it stands to
reason that one considers the least costly option. Therefore, due to high cost of remote
monitoring, the data suggest that standard care be considered.
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CHAPTER FIVE: DISCUSSIONS AND CONCLUSIONS
The Heart Failure Association of America warns that HF affects nearly five million
Americans and is the only major cardiovascular disease that is increasing among people aged 65
and older. This study represented an attempt to understand the potential effect of remote
monitoring in patients with heart failure. In doing so, this study sought to answers three
questions:
1. To what extent does the cost per outcome justify the use of remote monitoring in
patients with HF?
2. To what degree is remote monitoring in home care used to affect positive change in
the process of care?
3. In an effort to decrease the costs of accessible quality care, can remote monitoring be
used as an intervention strategy to affect positive changes in health and cost outcomes
among patients with HF?
To answer these questions, seven hypotheses were presented and six were tested. H2b was not
tested due to no EDV related heart failure in this data set. Table 21 is a summary of the
hypotheses and results.

Results of Hypothesis Testing
H1: When structural factors are held constant, better care structure leads to better
clinical process.
H1a: There is a statistically significant difference in skilled nursing utilization between
the standard of care and remote monitoring care groups in patients with HF.
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H1b: There is a statistically significant difference in Net HHRG (net income) between
the standard of care and remote monitoring care groups in patients with HF.
H1c: There is a statistically significant difference in agency costs between the standard of
care and remote monitoring care groups in patients with HF.
Hypothesis H1 sought to answer research question number one: This analysis involved
examining the number of skilled nursing visits, net HHRG, and agency administrative costs.
Results suggested a statistically significant difference in skilled nursing visits and administrative
costs that favored the usual care program. The remote monitoring group had a statistically
significant increase in the number of skilled nursing visits and administrative costs. The average
agency profit per patient was not statistically significant between the groups. The agency
experienced similar average income per patient. Thus, the remote monitoring group increased the
financial burden on the agency, with no change in income to offset the cost of the program.
Fiscally, the remote monitoring program was not advantageous as compared to the usual care
group; from the cost outcomes ratio analysis, the cost per outcome does not justify the use of
remote monitoring.
Hypothesis two sought to answer question two of the study.
H2: When structural factors are held constant, better care process leads to better clinical
outcomes.
H2a: There is a positive relationship between decision-making and rate of hospital
readmissions in patients with HF.
H2b: There is a positive relationship between decision-making and rate of emergency
department visits in patients with HF.
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The AID: Dtreg analysis suggested that decision-making by the clinician was a critical
factor in hospitalizations. The data suggested that patient education, clinical interventions, and
physician notification prior to hospitalization were not significantly used. Clinician behavior
was contrary to the purposes of remote monitoring; the use of data to enact early interventions
to mitigate the need for hospital utilization was not demonstrated in this study.
H3: The structure positively affects the process of care that will lead to better care
outcomes.
H3a: Remote monitoring positively affects the process in home health care that will lead
to statistically significant differences in health outcomes for patients with HF.
H3b: Remote monitoring positively affects the process will lead to statistically significant
differences in cost outcomes for patients with HF.
No significant difference was noted in remote monitoring and usual care groups. Results
suggested that remote monitoring does not statistically lead to a decrease in heart failure-related
hospital readmissions and all-cause emergency department visits. Data also suggested that all
heart failure-related emergency department visits led to hospital readmissions. Statistical
significance revealed differences in pre- and posttest measures for dyspnea, but no difference
between groups were noted. While participants who completed 51 to 75 percent of remote
monitoring also demonstrated a relative increase in the average number of heart failure
symptoms, no conclusion can be drawn from this result. The sample size for this group was
relatively small. Due to low sample size across compliance rates, no conclusions can be made
about compliance and hospitalization risks.
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Table 22 Summary of Hypothesis and Results
Relationship
Expected Actual

Hypothesis
Structure and Process
H1: When structural factors are held constant, better care structure leads to better clinical process
H1a: There is a statistically significant difference in skilled nursing utilization
between the standard of care and remote monitoring care groups in patients with HF.

(+)

(+)

H1b : There is a statistically significant difference in Net HHRG (net income) between
the standard of care and remote monitoring care groups in patients with HF.

(+)

(-)

H1c: There is a statistically significant difference in agency costs between the
standard of care and remote monitoring care groups in patients with

(+)

(+)

Summary

Higher skilled nursing utilization
was noted in the remote
monitoring group
No difference was noted in net
HHRG between groups
Higher skilled nursing utilization
was noted in the remote
monitoring group

Process and Outcomes
H2: When structural factors are held constant, better care process leads to better clinical outcomes
H2a: There is a positive relationship between decision-making and rate of hospital
readmissions in patients with HF.

(+)

(+)

A relationship was found between
hospital readmission and clinician
recommendation

H2b: There is a positive relationship between decision-making and rate of emergency
department visits in patients with HF.

(+)

n/a

This could not be tested as no
EDV due to HF was detected

Structure - Process Interaction Influence on Outcomes
H3: The structure positively affects the process of care will lead to better care outcomes
H3a: Remote monitoring positively affects the process in home health care will lead
to statistically significant differences in health outcomes for patients with HF.

(+)

(-)

Interaction of structure and process
resulted in little influence on
health outcomes

H3b: Remote monitoring positively affects the process in home health care will lead
to statistically significant differences in cost outcomes for patients with HF.

(+)

(-)

Interaction of structure and process
resulted in little influence on cost
outcomes

Statistically Significant at p > 0.05; H3
Statistically Significant at p < 0.05; H1, H2
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Significance of Results and Theoretical Importance
The Donabedian Quality Model offers a framework for the impact of structure on
process, process on outcomes, and the interaction of structure and process on outcomes. By
embedding a formative analysis, offered by the SPO Model, remote monitoring was offered as a
technological infrastructure or input to support an intervention program. In this manner, each
component of the program was conceptualized and examined as a critical component to improve
quality outcomes of patient with HF.
Structure and Process
H1: When structural factors are held constant, better care structure leads to better clinical
process.
In this study, structure had little positive influence on the care process. The structural
inputs as seen in the SPO Model (Figure 2) and the results of this study suggest that the inputs
into the system had little influence on the process. The addition of a technological structure
complicated the process through the increased number of skilled nursing visits, increased
agency costs, and little change in net income to the organization. This increased the cost of care
confounded agency cost through an increase in intensity of service utilization without offsetting
agency investment into the technology.
Process and Outcomes
H2: When structural factors are held constant, better care process leads to better clinical
outcomes.
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The data in this study suggest that the clinical process had a significant influence on the
outcome. This supports Donabedian’s framework of process influence on outcomes. However,
the outcomes were not favorable due to an inadequate process of care. While other options were
available that might have facilitated favorable outcomes, they were not implemented. Based on
the data, clinicians in this facility showed little evidence that patient education, clinical
interventions, or physician contact were initiated before hospital recommendations. This has
significant implications for the need for clinical education on the influence of process of care on
outcomes. While structure may influence the process, the clinicians’ decision to harness the
strength of technology (timely physiological information) in the clinical process was critical to
hospital utilization. When the clinical decision-making favored an increase in the complexity of
care, there was a high utilization of hospital services.
Interaction of Structure and Process on Outcomes
H3: The structure positively affects the process of care will lead to better care outcomes.
The lack of influence of structure on process was problematic for this study. Remote
monitoring had little influence on the process of care. howver, the model suggest that process has
a greater influence on cost and health care outcomes, than do structure. Health information
technology is a resource intensive investment, therefore, one should ask – to what degree can
process be improved without the added financial burden of remote monitoring?
The results of the study, using the Donabedian Models, suggested that the structure was
inadequate to affect change in outcomes. The SPO model suggested that processes are critical to
the success of the remote monitoring program. However, more studies are needed to determine
the interaction of structure and process on outcomes.
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Practical Use
Clinical Use. Fundamental to efficacious clinical decisions are information exchange
(Feldman & Horan, 2011). Effective information exchanges in health care can enhance
collaboration for decision-making and care coordination (Feldman & Horan, 2011). Health
information technology (HIT) has the potential to increase the utilization of organizational
resources by enabling practitioners to work together with reliable and valid health data (Nevo &
Wade, 2010). Under this framework, the introduction of information technology in health care is
critical to health care reform. The information clinicians obtained from it should be considered in
the care process that favors alleviation of symptoms at lower levels of care.
The role of nursing care in heart failure management, whether in hospital or community
based care, is critical quality outcome. When patients have heart failure symptoms, it is
important for clinicians to recognize the signs and symptoms, and be able to ascertain and
implement the most appropriate clinical intervention. The nursing staff must be able to
collaborate with team members and physicians to provide the best possible care. The status of the
health care system deems that sending patients to the hospital for symptom management is not
acceptable. Clinical decisions are related to quality and cost, and quality and cost are interrelated
themselves (Donabedian, 1983).
Collaborative Practice. Collaborative practice in the home health setting is challenging.
The clinicians are relatively autonomous as they work independently in patient’s home. Contacts
with other clinicians occur during staff meetings, telephone, or email communications, which
may inhibit timely care if clinical questions remain unresolved for prolonged periods. Therefore,
the level of care is highly dependent upon the skill of the treating clinician. Geographic barriers
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inherent between the home care providers and the medical offices increase the difficulty for
alerting physicians, as many times a phone call must be made (Guggiano, Brown, Hristidis, &
Page, 2013). Therefore, potentially urgent matters may not be immediately addressed while
home care clinicians await orders from the treating doctor. While remote monitoring may
provide timely information and alert staff to physiological deterioration, changes in plan of care
as a result of this information, must be cleared through the physicians who are likely unavailable
immediately to address these issues. This delays the coordination of care that remote monitoring
is stipulated to support. The literature suggested that while health information technology may
increase the availability of information, the flow of information amongst providers may be
inadequate (Mäkelä et al., 2013). The integration of remote monitoring and other smart home
technologies in home care suggested that the process of care (and communication) among home
care clinicians and physician office practices must be adequately addressed.
Accountable Care Organizations. Recent legislation such as the Hospital Readmission
Penalty discourages hospital overutilization. While this legislation primarily penalizes hospitals,
home health agencies with high hospital readmission rates will not be viable partners with
hospitals, if hospital objectives cannot be met. Therefore, while it is laudable to adopt
intervention programs to decrease hospital readmissions, this study suggests that a greater focus
on the interaction between technology and clinicians should be emphasized to promote better
care processes.
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Policy Relevance
Influenced by the passage of the Patient Protection and Accountable Care Act (PPACA)
and Health Information Technology for Economic and Clinical Health Act (HITECH), the health
care system is under pressure to control costs (Blumenthal, 2009). Cost control will be achieved
with interventions that mitigate preventable health complications (Orszag & Emanuel, 2010).
Ten percent of patients account for 64 percent of cost, and many of these patients are diagnosed
with heart failure, diabetes, and hypertension (Orszag & Emanuel, 2010). Therefore, the
exploration of remote monitoring to facilitate quality management of these ailments is
reasonable.
Technology, while it shapes human action making some actions possible, requires the
deliberate action and support from health care professionals (Greenhalgh & Swinglehurst, 2011).
Used appropriately, remote monitoring should enhance delivery care models, processes, and
patient care team interactions (Cheitlin, 2012). HITECH and PPACA recognize that data
collection is not an end in itself, but the information it provides should be implemented to
efficiently allocate resources (Buntin et al., 2010; Classen & Bates, 2011). This study suggests
that the mere adoption of technology does not increase efficiency and the effectiveness of health
care organizations to deliver care. Further examination of the process of clinical care raises
concerns about the utility of the information and resultant decisions. This study suggests that
preoccupation with technology should be shifted to the evaluation of the process of providing
medical care.
Recognizing these ideals, CMS defines meaningful use of technology to:
1. Improve quality, safety efficiency, and reduce health disparities,
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2. Engage patient and families in their health care,
3. Improve care coordination,
4. Improve population and public health, and
5. Maintain privacy and security.
Meaningful use of remote monitoring requires that valid health information be submitted
electronically to affect positive change in clinical processes and outcomes. Therefore, the health
information derived from remote monitoring should be influential in clinical strategies that
promote early interventions before hospital utilizations are necessary.
Appendix F provides a summary of recent legislation to support the use of advance
communication and health information technology. From this table, one sees a relatively large
amount of fiscal resources devoted to the clinical use of advance information technology.

Methodological Rigor
Prior studies have examined the structure of remote monitoring and its direct influence on
quality outcomes. Prospective studies have been plagued with limitations due to sample size. A
high mortality rate (drop out) of participants was noted, leaving an inadequate effect size to
validate the findings. Other studies have noted that the Hawthorne Effect may be an issue to
those on the remote monitoring. Clinicians were noted to provide more clinical care and patient
education to the remote monitoring group than the control group. As a retrospective study,
opportunities for inequalities are lessened. Propensity score analysis was used to decrease
selection bias and inequalities among the groups. Dtreg was used to examine the influence of
decision-making on hospital utilization.
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Limitations
This retrospective case control design does not allow for true random assignment. While
propensity score matching and analysis were used to alleviate selection bias, interpretation of the
results should be cautiously considered. Other variables of interest may include health literacy
and patient compliance and their effects on patient quality outcomes.
Hospital Utilization Outcomes. External validity of the study was limited due to the high
rate of hospital readmissions and the low rate of emergency department visits found in this data
set. Although Medicare stipulates that home health care admission is required within 24 hours of
hospital discharge, extenuating circumstances may dictate that home care admissions were
prolonged. Although secondary diagnosis, readmission diagnosis, and EDV diagnosis was
considered in this study, the influence of exacerbating co-morbidities is difficult to control.
Cost Outcomes Ratio. The limitations for the cost analysis for this study site are
recognized. The results of the study are limited in their generalizability. External validity was
limited in this study due to the fiscal vulnerability of this organization. While a national
organization, it has undergone several changes. In 2012, it bought another nationally recognized
agency. In late 2013, they were purchased by another agency. This underscores the financial
instability of the organization. The variability among organizational structures and processes in
the use of remote monitoring among home care agencies also contributes to its lack of external
validity. It was difficult to ascertain whether leasing or buying would be more advantageous to
the organization, as this agency used leased and purchased monitoring units. The patients’ ability
to understand and apply health care instructions may contribute to nursing utilization, as well.
This study did not consider health literacy and technology acceptance of remote monitoring or
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the number of face-to-face visits with physicians that decreased the need for home nursing care
visits.
Clinical Outcomes. Interval validity and reliability is also called into question as a review
of the medical record demonstrated clear inconsistencies between nursing visits. It is
questionable whether continuity of care existed between clinicians with discrepancies in
addressing similar issues. The data for the study was obtained by the Outcome and Assessment
Information Set (OASIS), which is used by CMS to gather patient clinical and functional
information. There was potential for variability in ascertaining such information as the ability to
respond to questions appropriately is dependent upon skill level of the clinicians, and familiarity
with how to answer questions. Clinician education should be uniformly taught to increase the
consistency and accuracy in answering OASIS questions. The variability in sample size among
the groups suggests that caution should be applied when interpreting the results.

Recommendation for Future Research
The clinical and economic impact of heart failure suggests a failing health care system
that inadequately addresses the needs of a growing majority. Health care agencies consider
viable intervention programs to mitigate such ill effects. Future clinical outcomes studies should
consider the New York Functional Classification Scale for its reliability and validity in clinical
practice and research as a measure of functional outcome or as a measure of patient classification
(Bennett, Riegel, Bittner, & Nichols, 2002; Goldman, Hashimoto, Cook, & Loscalzo, 1981).
The results of the study suggested that mere adoption of technology is clinically
ineffective and is economically detrimental to the agency. Future research should emphasize the
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process of providing care. The adaptation structuration theory may be used to consider how
clinicians use the information for decision-making and collaborate amongst themselves from a
socio-technological perspective. Thus, the value of the information gained from remote
monitoring derives from the decisions they support. It is generally accepted in medical literature
that compliance rate to an intervention program affects hospitalization rate and health care costs.
Further research is needed to determine optimal compliance rates for significant changes in
quality outcomes with remote monitoring. Methods to increase compliance among patients are
also critical to this program. Collaborative scales should be used in future studies to examine the
degree to which remote monitoring information enhances patient-clinician and clinician to
clinician collaboration.
Cost evaluation studies may consider cost effectiveness analysis. Cost effective research
(CER) offers an opportunity for public health initiatives to be supported by solid evidence of
their effectiveness. It enhances the decision-making process by identifying which intervention
strategies have superior outcomes, reconsiders commonly pursued strategies, and draws attention
to underutilized programs (Saver, 2011). Therefore, instead of asking does this work, CER
evaluates how different intervention strategies compare to each other. Current studies suggest
that the lack of well-functioning remote monitoring programs and inadequate methodological
rigor in economic evaluations permeates telehealth studies. Cost effectiveness analysis may be
performed with the Markov model. This decision-making model is used to determine the
probability of emergency room visits, hospitalization, and mortality in the intervention or
comparison group. Costs analysis may include direct medical care and the additional cost of the
intervention program. A sensitivity analysis, using incremental cost effectiveness, may account
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for assumptions and uncertainties in the model, while considering quality-adjusted life-years
(QUALY).
Future studies may also consider a cost-benefit analysis from the user’s perspective.
Endpoints to consider may include indirect cost to the system such as a caregiver’s time from
work for transportation, and patient visits to the physician’s office.
As the field continues to consider the use of technology in health care, health care
professionals and researchers should consider process of care as a patient-centered task, where
human performance is valued over tasks-oriented care. The focus on tasks leads professionals to
provide care as isolated tasks, where fragmentation of care exists (Walker & Carayon, 2009).
This leads to the lack of collaboration of care; hence, patients are moved from one health care
setting to another and exacerbations in health status are not resolved at the lower levels of care.
The valuing of care process design has led to the term “human performance technology” in
health care, replacing the term “clinical process” (Kulhanek & Kulhanek, 2013; Walker &
Carayon, 2009). This supports future research in human-factors engineering, pay-forperformance, and total quality management in health information technology (Walker &
Carayon, 2009). The adoption of new technologies should accompany a cultural change to
support the advantage that technology provides.
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APPENDIX A: SIGNIFICANCE OF HOSPITAL READMISSIONS
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Significant of Hospital Readmissions
* National health care spending was postulated to be $2.6 trillion FY 2010; 17.7 %
of GDP
* Hospital Readmissions $17.4 billion out of $102.6 billion in total hospital
payments
* 20% of all Medicare beneficiaries are readmitted within 30 days of hospital
discharge
* 34% of all Medicare beneficiaries are readmitted within 90 days of hospital
discharge
* Hospital Compare Website reveals that 30 day readmission rate for HF remains
largely unchanged from 2007 to 2010 (Kosher & Adashi, 2011).
* Department of Health and Human Services strategic plan for 2010-2015 cites
payment incentives to reduce readmissions,
* Center for Medicare and Medicaid Services' National Strategy for Quality
Improvement in Health Care seeks to decrease readmission rates by 20% by end of
2013 (Kosher & Adashi, 2011); preventing 1.6 million hospitalizations and saving
approximately $15 billion
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APPENDIX B: SUMMARY OF INFLUENCE OF HEART FAILURE
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Influence of Heart Failure
* Heart failure is the most common cause of hospitalizations
among Medicare recipients, accounting for 1.4 million
hospitalizations annually
* Prevalence rate: 5.6 million with 400,000 diagnosed
annually
* Congestive Heart Failure, 1/10 die within 30 days of
hospitalizations; 1/4 have high readmission rates
* 59% of men and 40% of women are die within 5 years of
diagnosis
* FY 2010, indirect and direct costs of Heart failure estimated
to be $39.2 billion

98

APPENDIX C: SUMMARY OF THE LITERATURE OF REMOTE
MONITORING EFFECTS ON QUALITY
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Summary of Telemedicine Effects on Quality
Reference
Diagnosis
Technology
Antonicelli et
al. (2010)

Clark et al.
(2007)

Intervention

Clinical Outcomes

Economic Outcomes

CHF

Home telemonitoring

12 months

Significant decrease in
mortality and hospital
readmission in TM
(P<0.01)

CHF

Home
Telemonitoring;
Telephone Support

Systematic
Review

Systematic Review.
Remote monitoring
decrease admission by
21%;mortality by 20%

Reduce Health Care
cost
Reduce Health Care
cost via decrease
admissions, Video
$22.11, TM $33.11,
and face-to-face
$48.27 per visit

N/A

Finkelstein et
al. (2006)

CHF; COPD

Home
Telemonitoring;
Video Conference

6 month

No significant difference
in mortality rates.
Significant difference in
hospital admissions.

Trappenburg
et al. (2008)

COPD

Home
Telemonitoring

6 month

Decreased hospital
admission; Decreased
length of stays

N/A

Vitacca et al.
(2009)

COPD

Telephone

12 months

Decreased hospital
admission; decreased ED

33% lower costs for
TM

Willems et al.
(2007)

COPD

Home
Telemonitoring

12 months

No significant difference
in mortality rates.
Significant difference in
hospital admissions.

N/A

Bowles et al.
(2009)

CHF;
Diabetes

Home
Telemonitoring;
Telephone
Support+TM

120 days

No significant difference
in mortality rates.
Significant difference in
hospital admissions.

N/A
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Reference

Diagnosis

Dansky et al.
(2008)

Chronic
Disease

Jerant et al.
(2001)

CHF

Pare et al.
(2006)
Polisena et al.
(2010)
"Home
monitoring
cuts cardiac
readmissions"
Tompkins et
al. (2010)
Dang et al,
(2009)

COPD
CHF

CHF

CHF
CHF

Technology
Home
Telemonitoring; One
way monitor; two
way monitory; video

Intervention

Clinical Outcomes

Economic Outcomes

120 days

No significant difference
in mortality rates.
Significant difference in
hospital admissions.

N/A

12 months

(+ ) Readmissions in both
intervention groups (-) no
between group differences

N/A

6 months

(+) Readmissions

(-) Cost Agency

Systematic
Review

(+) Readmissions (+)
Mortality Rate

N/A

Home
Telemonitoring

60 days

(+) Readmissions

N/A

Home
Telemonitoring
Home
Telemonitoring

Systematic
Review
Systematic
Review

(-) Readmissions (-)
Mortality
(+) Readmissions (+)
Mortality Rate

Home Video;
Telephone Support;
Outpatient Care
Home
Telemonitoring
Home
Telemonitoring
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(-) Cost Agency
N/A

APPENDIX D: SUMMARY OF COST ANALYSIS OF REMOTE
MONITORING
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Summary of Cost Analysis of Remote Monitoring
Reference
Diagnosis
Whitten et al. (2002)
HF; Systematic Review
Dansky et al. (2001)

HF; Diabetes

Seto, (2008)

HF; Systematic Review

Tompkins et al. (2010)

HF

Vitacca et al. (2009)

COPD
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Economic Outcomes
Negative - Agency/Health Care
Negative - Agency level;
Positive - Health care costs
Negative - Agency level;
Positive - Health care costs
Negative - Agency level;
Positive - Agency level; Positive
- Health care costs

APPENDIX E: OPERATIONALIZATION OF STUDY VARIABLES
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Operationalization of Study Variables
Construct
Heart Failure
Endogenous Hospital
HA TIF
Readmissions
Emergency Visits
ED
Marital Status
MS
Intent to Treat
Exogenous

TM
Age
Race
Gender
Chronic Obstructive
Pulmonary Disease
Congestive Heart
Failure
Social Environment
Social Support

Definition
0 = None, 1 = Yes
0 = None, 1 = Yes
1 = Single, 2=Married, 3=Widowed, 4 = Divorced
0 = 0 percent completion of any remote monitoring, 1 = .001 to
.25 completion of remote monitoring, 2 = .26 to .50 of remote
monitoring completion, 3-.51 to .75 completion of remote
monitoring; and 4 = .76 to 1.00 completion
Age in years
1= White, 2 = Black, 3 = Hispanic, 4 = Asian
1= Male, 2 = Female

COPD

See 1005 in Appendix G

CHF

See 1005 in Appendix G

M1100
M2110

See M1100 in Appendix G
See M2110 in Appendix G
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Construct
Clinical Acuity

Definition
level of clinical status as determined by OASIS scoring 0 to 20
(low to high)
level of functional status as determined by OASIS scoring 0 to
20 (low to high)

Functional Acuity
M1034
M1400
M1500
M1860
M1700
M1730

Overall
Status
Short of
Breath
Symptom
of CHF
Ambulation

See M1034 in Appendix G
See M1400 in Appendix G
See M1500 in Appendix G
See M1860 in Appendix G
See M1700 in Appendix G
See M1730 Appendix G
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APPENDIX F: SUMMARY OF HEALTH LEGISLATION TO
SUPPORT HEALTH QUALITY AND TECHNOLOGY USE
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Summary of Legislation for Health Care Information Technology Use
Initiatives
Enacted/Mandated
Provisions
* Hospital Readmission
Reductions- Alter means of
March 23, 2010 by
Patient Protection and
payment in efforts to improve
President Barack Obama
Affordable Care Act
quality and eliminate high cost
and the 111th United
(PPACA)
areas * Supports Health
States Congress
Information Technology
infrastructure.

Health Information
Mandated by American
* Funding support for Health
Technology for Economic Recovery and
Information Infrastructure
and Clinical Act
Reinvestment Act of 2009

Beacon Community
Cooperative Agreement
Program

Mandated by American
* Promulgates meaningful use
Recovery and
of Health Information
Reinvestment Act of 2009 Technology

Regional Extension
Center and State Health
Information Exchange

HITECH Initiative

National Pilot Program on
Mandated by ACA
Payment Bundling
Section 3023
(NPPPB)

*Support for exchanging
information across health care
systems
* Bundling of Medicare
payments into a single
comprehensive fee for an
episode of care
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Fiscal Support

$20 billion in health
information technology
infrastructure; $40,000 $60,000 for physicians
demonstrating meaningful use;
hospital eligible for > $1
million
$255.3 million grant, along
with additional $15 million in
evaluation and technical
assistance to fund education
Thus far, $547,703,428
awarded to 56 states, eligible
territories, and qualified state
designated entities
5 year voluntary effort with
CMS oversight

Initiatives

Enacted/Mandated

Independence at Home
Demonstration Program
(IAHP)

Mandated by ACA,
Section 3024

Hospital Readmission
Reduction Program
(HRRP)

Mandated by ACA
Section 3025

Community-Based Care
Transition Program
(CCP)

Mandated by ACA,
Section 3026

Provisions
Fiscal Support
* Home Based Primary care
teams directed by physicians or
3 years $25 million program
nurse practitioners for home
bound seniors
*Aligns payments with quality
outcomes, projected to begin
FY 2013
*Reduce hospital admissions by
targeting quality and safety of
care transitions between
inpatient and outpatient arenas. 5 year-$500 million program
Supports partnerships between
hospitals and community based
organizations.
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APPENDIX G: OASIS DATA SET INCLUDED IN THIS STUDY
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(M0140) Race/Ethnicity:
1 - American Indian or Alaska Native
2 - Asian
3 - Black or African-American
4 - Hispanic or Latino
5 - Native Hawaiian or Pacific Islander
6 - White
(M1000) From which of the following Inpatient Facilities was the patient discharged during the past 14 days? (Mark all that apply.)

⃞ 1 - Long-term nursing facility (NF)
⃞ 2 - Skilled nursing facility (SNF / TCU)
⃞ 3 - Short-stay acute hospital (IPP S)
⃞ 4 - Long-term care hospital (LTCH)
⃞ 5 - Inpatient rehabilitation hospital or unit (IRF)
⃞ 6 - Psychiatric hospital or unit
⃞ 7 - Other (specify)
⃞ NA - Patient was not discharged from an inpatient facility [Go to M1016 ]
(M1005) Inpatient Discharge Date (most recent):
__ __ /__ __ /__ __ __ __
month / day / year
Rate the degree of symptom control for the condition listed in Column 1 using the following scale:
0 - Asymptomatic, no treatment needed at this time
1 - Symptoms well controlled with current therapy
2 - Symptoms controlled with difficulty, affecting daily functioning; patient needs ongoing monitoring
3 - Symptoms poorly controlled; patient needs frequent adjustment in treatment and dose monitoring
4 - Symptoms poorly controlled; history of re-hospitalizations
Note that in Column 2 the rating for symptom control of each
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(M1020) Primary Diagnosis & (M1022) Other Diagnoses
Column 1
Diagnoses (Sequencing of diagnoses
should reflect the seriousness of each condition and
support the disciplines and services provided.)

Description

(M1024) Payment Diagnoses
(OPTIONAL)

Column 2
ICD-9-C M and
symptom control rating for each
condition.
Note that the
sequencing of these ratings
may not match the sequencing
of the diagnoses

Column 3
Complete if a V-code
is assigned under certain
circumstances to Column 2 in
place of a case mix diagnosis.

Column 4
Complete only if the
V-code in Column 2 is reported
in place of a case mix
diagnosis that is a multiple
coding situation (e.g., a
manifestation code).

ICD-9-C M /
Symptom Control Rating

Description/ ICD-9-C
M
(V- or E-codes NOT
allowed) a.

Description/ ICD-9-C
M
(V- or E-codes NOT

(M1020) Primary Diagnosis

(V-codes are
allowed)

a.

allowed)

(__ __ __ . __ __)

a. (__ __ __ . __ __)

a.
(__ __ __ . __ __)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
(M1022) Other Diagnoses

(V- or E-codes are
allowed)

b.

(V- or E-codes NOT
allowed) b.
(__ __ __ . __ __)

b. (__ __ __ __ . __
__)

(V- or E-codes NOT
allowed)
b.
(__ __ __ . __ __)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
c.

c. (__ __ __ __ . __
__)

c.

c.
(__ __ __ . __ __)

(__ __ __ . __ __)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
d.

d. (__ __ __ __ . __
__)

d.

d.
(__ __ __ . __ __)

(__ __ __ . __ __)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
e.

e. (__ __ __ __ . __
__)

e.

e.
(__ __ __ . __ __)

(__ __ __ . __ __)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
f.

f. (__ __ __ __ . __
__)

⃞0 ⃞1 ⃞2 ⃞3 ⃞4
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f.

f.
(__ __ __ . __ __)

(__ __ __ . __ __)

(M1034) Overall Status: Which description best fits the patient’s overall status? (Check one)

⃞ 0 - The patient is stable with no heightened risk(s) for serious complications and death (beyond those typical of the patient’s age).
⃞ 1 - The patient is temporarily facing high health risk(s) but is likely to return to being stable without heightened risk(s) for serious complications and
death (beyond those typical of the patient’s age).

⃞ 2 - The patient is likely to remain in fragile health and have ongoing high risk(s) of serious complications and death.
⃞ 3 - The patient has serious progressive conditions that could lead to death within a year.

⃞ UK - The patient’s situation is unknown or unclear.
LIVING ARRANGEMENTS

(M1100) Patient Living Situation: Which
of the following best describes
the patient's residential
circumstance and availability of
assistance? (Check one box
only.) Living Arrangement
a. Patient lives alone

Availability of Assistance
A
round
the
clock

Regul
ar daytime

Regul
ar nighttime

Occasi
onal / shortterm assistance

No
assistance
available

⃞ 01

⃞ 02

⃞ 03

⃞ 04

⃞ 05

b. Patient lives with other person(s)
⃞ 06
in the home

⃞ 07

⃞ 08

⃞ 09

⃞ 10

c. Patient lives in congregate
situation (e.g., assisted living)

⃞ 12

⃞ 13

⃞ 14

⃞ 11
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⃞ 15

RESPIRATORY STATUS
(M1400) When is the patient dyspneic or noticeably Short of Breath?

⃞ 0 - Patient is not short of breath
⃞ 1 - When walking more than 20 feet, climbing stairs
⃞ 2 - With moderate exertion (e.g., while dressing, using commode or bedpan, walking distances less than 20 feet)
⃞ 3 - With minimal exertion (e.g., while eating, talking, or performing other ADLs) or with agitation

⃞ 4 - At rest (during day or night)
(M1500) Symptoms in Heart Failure Patients: If patient has been diagnosed with heart failure, did the patient exhibit symptoms indicated by clinical
heart failure guidelines (including dyspnea, orthopnea, edema, or weight gain) at any point since the previous OASIS assessment?

⃞ 0 - No [ Go to M2004 at TRN; Go to M1600 at DC ]
⃞ 1 - Yes
⃞ 2 - Not assessed [Go to M2004 at TRN; Go to M1600 at DC ]
⃞ NA - Patient does not have diagnosis of heart failure [Go to M2004 at TRN; Go to M1600 at DC ]
(M1510) Heart Failure Follow-up: If patient has been diagnosed with heart failure and has exhibited symptoms indicative of heart failure since the
previous OASIS assessment, what action(s) has (have) been taken to respond? (Mark all that apply.)

⃞ 0 - No action taken
⃞ 1 - Patient’s physician (or other primary care practitioner) contacted the same day
⃞ 2 - Patient advised to get emergency treatment (e.g., call 911 or go to emergency room)
⃞ 3 - Implemented physician-ordered patient-specific established parameters for treatment
⃞ 4 - Patient education or other clinical interventions

⃞ 5 - Obtained change in care plan orders
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(M1700) Cognitive Functioning: Patient's current (day of assessment) level of alertness, orientation, comprehension, concentration, and immediate
memory for simple commands.

⃞ 0 - Alert/oriented, able to focus and shift attention, comprehends and recalls task directions independently.
⃞ 1 - Requires prompting (cuing, repetition, reminders) only under stressful or unfamiliar conditions.
⃞ 2 - Requires assistance and some direction in specific situations (e.g., on all tasks involving shifting of attention), or consistently requires low stimulus
environment due to distractibility.

⃞ 3 - Requires considerable assistance in routine situations. Is not alert and oriented or is unable to shift attention and recall directions more than half
the time.

⃞ 4 - Totally dependent
(M1730) Depression Screening: Has the patient been screened for depression, using a standardized depression screening tool?

⃞ 0-

⃞ 1 - Yes, patient was screened
using the PHQ-2©* scale. (Instructions for
this two-question tool: Ask patient: “Over
the last two weeks, how often have you
been bothered by any of the following
problems”) Not at all
0 - 1 day

Several
days
2-6
days

More
than half of the
days
7 – 11
days

Nearly
every day
12 – 14
days

No

N/A
Unable
to respond

P
H
Q
2
©
*

a) Little interest or pleasure in doing things

⃞0

⃞1

⃞2

⃞3

⃞na

b) Feeling down, depressed, or hopeless?

⃞0

⃞1

⃞2

⃞3

⃞na
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(M1860) Ambulation/Locomotion: Current ability to walk safely, once in a standing position, or use a wheelchair, once in a seated position, on a variety
of surfaces.

⃞ 0 - Able to independently walk on even and uneven surfaces and negotiate stairs with or without railings (i.e., needs no human assistance or assistive
device).

⃞ 1 - With the use of a one-handed device (e.g. cane, single crutch, hemi-walker), able to independently walk on even and uneven surfaces and
negotiate stairs with or without railings.

⃞ 2 - Requires use of a two-handed device (e.g., walker or crutches) to walk alone on a level surface and/or requires human supervision or assistance to
negotiate stairs or steps or uneven surfaces.

⃞ 3 - Able to walk only with the supervision or assistance of another person at all times.
⃞ 4 - Chairfast, unable to ambulate but is able to wheel self independently.
⃞ 5 - Chairfast, unable to ambulate and is unable to wheel self.

⃞ 6 - Bedfast, unable to ambulate or be up in a chair.
(M2110) How Often does the patient receive ADL or IADL assistance from any caregiver(s) (other than home health agency staff)?

⃞ 1 - At least daily
⃞ 2 - Three or more times per week
⃞ 3 - One to two times per week
⃞ 4 - Received, but less often than weekly
⃞ 5 - No assistance received

⃞ UK - Unknown [Omit “UK” option on DC]

116

EMERGENT CARE
(M2300) Emergent Care: Since the last time OASIS data were collected, has the patient utilized a hospital emergency department (includes
holding/observation)?

⃞ 0 - No [ Go to M2400 ]
⃞ 1 - Yes, used hospital emergency department WITHOUT hospital admission
⃞ 2 - Yes, used hospital emergency department WITH hospital admission
⃞ UK - Unknown [ Go to M2400 ]
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(M2310) Reason for Emergent Care: For what reason(s) did the patient receive emergent care (with or without hospitalization)? (Mark all that apply.)

⃞ 1 - Improper medication administration, medication side effects, toxicity, anaphylaxis
⃞ 2 - Injury caused by fall
⃞ 3 - Respiratory infection (e.g., pneumonia, bronchitis)
⃞ 4 - Other respiratory problem
⃞ 5 - Heart failure (e.g., fluid overload)
⃞ 6 - Cardiac dysrhythmia (irregular heartbeat)
⃞ 7 - Myocardial infarction or chest pain
⃞ 8 - Other heart disease
⃞ 9 - Stroke (CVA) or TIA
⃞ 10 - Hypo/Hyperglycemia, diabetes out of control
⃞ 11 - GI bleeding, obstruction, constipation, impaction
⃞ 12 - Dehydration, malnutrition
⃞ 13 - Urinary tract infection
⃞ 14 - IV catheter-related infection or complication
⃞ 15 - Wound infection or deterioration
⃞ 16 - Uncontrolled pain
⃞ 17 - Acute mental/behavioral health problem
⃞ 18 - Deep vein thrombosis, pulmonary embolus
⃞ 19 - Other than above reasons

⃞ UK - Reason unknown
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APPENDIX H: SUMMARY FOR REASONS FOR HOSPITAL
READMISSIONS
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Table H-1 Summary for Reasons for Hospital
Readmissions
Reason for Emergent Care
Usual Care
Intervention
Total
M2430
Description
Frequency Percentage Frequency Percentage Frequency Percentage
2
Injury caused by fall
2
2.9
3
4.3
5
7.2
3
Respiratory infection
3
4.3
3
4.3
6
8.7
(e.g., pneumonia,
bronchitis
4
Other respiratory
1
1.4
2
2.9
3
2.9
problem
5
Heart failure (e.g., fluid
9
13
8
11.6
17
24.6
overload)
6
Cardiac dysrhythmia
2
2.9
0
0
2
2.9
(irregular heartbeat)
7
Myocardial infarction or
0
0
3
8.1
3
4.3
chest pain
9
Stroke (CVA) or TIA
1
3.1
0
0
1
1.4
11
GI bleeding,
0
0
1
1.4
1
1.4
obstruction,
constipation, impaction
13
Urinary tract infection
2
2.9
0
0
2
2.9
16
Uncontrolled pain
1
1.4
0
0
1
1.4
17
Acute mental/behavioral
1
1.4
0
0
1
1.4
health problem
19
Schedule treatment or
2
2.9
1
1.4
3
4.3
procedure
20
Other than Above
8
11.6
16
23.2
24
34.8

120

Figure H- 1. Summary of Reasons for Hospitalizations
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Table H-2 Reason for Emergency Department
Visits
Usual Care
M2310 Description
3
Respiratory
infection
(e.g.,
pneumonia,
bronchitis)
15
Wound
infection or
deterioration
19
Other than
above
reasons
99
Reason
unknown

Intervention

Total

Frequency Percentage Frequency Percentage Frequency Percentage
1
25
0
0
1
16.7

0

0

1

50

1

16.7

1

25

1

50

2

33.3

1

50

0

0

2

33.3
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APPENDIX I: DESCRIPTIVE RESULTS OF INTENT TO TREAT
FOR REMOTE MONITORING
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Descriptive Results for Intent to Treat of HF TIF
N
0
1
2
3
4
Total
Model

Fixed
Effects
Random
Effects

118
2
8
15
67
210

Mean
0.14
0
0.25
0.47
0.09
0.15

Std.
Deviation

Std.
Error

95% Confidence
Interval for Mean
Minimum Maximum
Lower
Upper
Bound Bound
0.07
0.2
0
1
0
0
0
0
-0.14
0.64
0
1
0.18
0.75
0
1
0.02
0.16
0
1
0.1
0.2
0
1

0.344
0
0.463
0.516
0.288
0.356

0.032
0
0.164
0.133
0.035
0.025

0.346

0.024

0.1

0.19

0.074

-0.06

0.35
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BetweenComponent
Variance

0.012

APPENDIX J: COST OUTCOMES OF USUAL CARE

125

Cost of Usual Care
Savings due to skilled
nursing utilizations

Average cost per visit

$40

Number of visits per patient
Direct benefits SN

13.05
$40 * 13.05

Net HHRG Score

$2,643.76

Net program costs

($40*13.05) $2643.76
Profit: 2121.76
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APPENDIX K: COST OUTCOMES OF REMOTE MONITORING
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Cost of Remote Monitoring
Savings due to
skilled nursing
utilizations

Average cost per visit

$40

Number of visits per patient
Direct benefits SN
Net HHRG Score
Net program costs + TM cost per patient
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17.06
$40 * 17.06
$2,624.12
($40*17.06) - $2624.12
Profit: 1,641.85

APPENDIX L OPERATIONALIZATION OF STUDY VARIABLES
FOR THE INTERACTION EFFECT OF STRUCTURE AND PROCESS ON
OUTCOMES
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Operationalization of Study Variables Interaction Effect of Structure and Process on
Outcomes
Covariate
Defined
Exogenous
Intent_1

0=0% to 49% , 3 = 51% to 75%, 4 = 76%
to 100% completion of remote
monitoring
0 - No action taken (1510 -0); 1 - MD
contacted the same day (1510-1); 2 Patient advised to get emergency
treatment (1510-2); 3 - Implemented
physician-ordered patient-specific
established parameters for treatment
(1510-3); 4 - Patient education or other
clinical interventions (1510-4); 5 Obtained change in care plan orders
(1510-5).

Process

Endogenous
Cost
Outcomes
Total Visits
NetHHRG1
episodeofcare
Agency Cost

Total skilled nursing visits for one
episode of care per patient
Net income in one episode of care per
patient
Total Visits minus Net HHRG per patient

Health
Outcomes
Total RA
Total ER

Hospital Readmissions per patient
Emergency department visits without
hospital readmission
1400DCdyspnea clinical status at discharge: 0 - No
shortness of breath, 1- walking more 20
feet, 2 moderate exertion, 3- minimal
exertion; 4- at rest
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APPENDIX M: INSTITUTIONAL REVIEW BOARD APPROVAL
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